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Thesis Summary 
In the healthcare setting, approximately 2 million bioinert devices are implanted into patients 
on an annual basis. However, interfacial instability of bioinert implants leads to reduced 
implant survivability and as a result revision surgery. Implant related infections are also a major 
concern which are associated with considerable repercussions for both the patient and 
healthcare system. Therefore, to overcome these failures materials that stimulate growth, repair 
and regeneration of tissues whilst simultaneously preventing infections need to be developed. 
A growing body of clinical data demonstrates that bioactive glasses offer great hope as they 
endorse these properties. Melt quench derived 3 mol% gallium doped bioactive glass was tested 
for antibacterial and cytotoxic activity. The results were compared with archetypal 45S5 
Bioglass®, prepared and processed under identical conditions to allow a direct comparison. The 
antibacterial activity was studied using Escherichia coli (NCTC 10538) and Staphylococcus 
aureus (ATCC 6538). The cytotoxic activity was evaluated using osteosarcoma Saos-2 cells 
and bone marrow derived mesenchymal stem cells. 
 
The group IIIa metal, gallium is known to possess antibacterial, antiresorptive and osteogenic 
properties and is therefore of interest for biological and tissue engineering applications. Results 
of the current work illustrated that 3 mol% gallium doped bioactive glass behaves in a similar 
manner to 45S5 Bioglass®. The antibacterial studies demonstrated that 3 mol% gallium doped 
bioactive and 45S5 Bioglass® do not possess a broad-spectrum antibacterial activity, as growth 
inhibition was only observed for E. coli; they were also rendered ineffective following pH 
neutralisation. Additionally studies with mammalian cells revealed that 3 mol% gallium doped 
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bioactive glass did not exhibit significant osteogenic activity, in comparison to 45S5 Bioglass®, 
after pH neutralisation.  
Keywords: gallium, antibacterial, cytotoxic, bioactive glasses 
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1.1 Structure and function of bone 
The adult human skeleton has a total of 213 bones and is composed of the axial and 
appendicular skeleton (Clarke, 2008). The four general categories of bones are long bones, 
short bones, flat bones and irregular bones (Clarke, 2008; Scanlon and Sanders, 2007). Long 
bones include bones of the arms, hands, legs and feet. Short bones include wrist and ankle 
bones, and the flat bones include ribs, shoulder blades, hip and cranial bones. Irregular bones 
include the vertebrae and facial bones (Scanlon and Sanders, 2007).  
 
The skeletal system provides both biomechanical support and metabolic supply for the entire 
body. The great rigidity and hardness of the bones of the skeletal system provide structural 
support for the rest of the body, protect the soft tissues of the thoracic, cranial and pelvic 
cavities, and permit movement and locomotion by providing levers for the muscles. It also 
contains and protects the red bone marrow, the primary haemopoietic tissue. Furthermore, the 
skeletal system also provides maintenance of mineral homeostasis; Calcium (Ca2+) may be 
removed from bone to maintain a normal blood Ca2+ level, which is essential for blood clotting 
and for muscle and nerve functioning. It also acts as a reservoir of growth factors and cytokines 
(Scanlon and Sanders, 2007; Clarke, 2008; Kini and Nandeesh, 2012).  
 
The bones have two structural components – the cortical bone and the trabecular bone (Kini 
and Nandeesh, 2012). The adult human skeleton is composed of 80% cortical bone and 20% 
trabecular bone (Clarke, 2008). Cortical bone is dense and solid and the trabecular bone is 
composed of a honeycomb like network of trabecular plates or rods interspersed in the bone 
marrow compartment (Clarke, 2008; Kini and Nandeesh, 2012). Trabecular bone is found in 
the ends of long bones and in the middle of most other bones, and it is always surrounded by 
the more durable cortical bone (Thompson, 2013). Cortical bone has an outer periosteal surface 
and inner endosteal surface (Clarke, 2008; Kini and Nandeesh, 2012). The periosteum is a 
dense fibrous connective tissue which contains osteoprogenitor cells, blood vessels and nerve 
fibres. It protects, nourishes, aides in bone formation and plays an important role in appositional 
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growth and fracture repair (Clark, 2005; Kini and Nandeesh, 2012). Furthermore, it also allows 
the attachment of tendons, ensuring a strong connection between muscle and bone (Thompson, 
2013; Clark, 2005). The endosteum is a thin membranous structure that covers the inner surface 
of cortical and trabecular bone and the blood vessel canals present in bone (Kini and Nandeesh, 
2012).  
 
Both cortical and trabecular bone are composed of smaller units called osteons (Clark, 2005; 
Clarke, 2008). Cortical osteons are called haversian systems, which are cylindrical in shape 
(Clarke, 2008). Through each osteon runs a haversian canal that contains small blood vessels 
and nerves (Clark, 2005). Layers of calcified bone matrix are arranged in concentric lamellae 
around a haversian canal (Clark, 2005; Thompson, 2013). Osteocytes occupy the lacunae, 
which are tiny gaps between the concentric lamellae and are interconnected by canaliculi 
(Clark, 2005; Thompson, 2013). The canaliculi and lacunae also contain interstitial fluid which 
bathes the osteocytes. This arrangement allows nutrients, gases and wastes and signalling 
molecules to diffuse to and from the osteocytes (Clark, 2005).  Volkmann’s canals or 
perforating canals, connect the haversian canals (Thompson, 2013). These canals transport 
blood and nutrients from the bones exterior to the central canals and the medullary or marrow 
cavity. Interstitial lamellae are incomplete osteons (because they remain during the remodelling 
process) which lie between the osteons (Clark, 2005) (Figure 1.1).  
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Figure 1.1The structure of bone (Nouri et al., 2010).  
 
Woven bone and lamellar bone are the 2 sub-tissue types in the skeletal system based on matrix 
organisation (Kini and Nandeesh, 2012). Lamellar bone formation is characterised by collagen 
fibres being laid down layer by layer in an orderly fashion. For each layer, collagen fibres are 
laid parallel to each other, forming a bone matrix sheet, which is called a lamella (Clarke, 2008 
& Kini and Nandeesh, 2012). Woven bone is produced when the collagen fibrils are laid down 
rapidly in a haphazard manner (Clark, 1958). Woven bone is weaker than lamellar bone and is 
produced during embryonic skeletal development, early fracture healing or the osteosarcoma 
formation. However, woven bone is short lived and is eventually replaced by lamellar bone 
(Kini and Nandeesh, 2012). 
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1.2 Bone formation and remodelling  
Bone is composed of bone forming cells, namely osteoblasts and remodelling cells, osteoclasts. 
Furthermore, it also consists of an organic matrix with inorganic mineral salts deposited within 
the matrix (Kini and Nandeesh, 2012). The organic matrix mainly consists of type I collagen 
fibres and non-collagenous structural proteins, which include proteoglycans, sialoproteins and 
osteocalcin (OCN) (Hadjidakis and Androulakis, 2006; Kini and Nandeesh, 2012). However, 
the role of non-collagenous proteins has not been fully explained (Hadjidakis and Androulakis, 
2006). The mineral content of bone hydroxyapatite [Ca10(PO4)6(OH)2], which is a crystalline 
complex of Ca2+ and phosphate (PO43-) (Clarke, 2008; Kini and Nandeesh, 2012). For 
biological tissues, the major form is carbonated hydroxyapatite, where PO43- or hydroxide can 
be substituted by carbonate. Traces of other minerals, such as magnesium, fluoride, potassium, 
sodium and chloride are also present in varying proportions (Lasch and Kneipp, 2008). 
 
Each bone constantly undergoes remodelling during life to help it to adapt to changing 
mechanical forces, as well as to remove old, microdamaged bone and replace it with new, 
mechanically stronger bone (Raggat and Partridge, 2010).  Bone remodelling occurs 
throughout life and can be divided into the following four phases (Figure 1.2): 
 
Activation phase: The first stage of bone remodelling involves detection of an initiating signal 
(Raggat and Partridge,2010), which could be direct mechanical strain on the bone that results 
in structural damage or hormone (e.g. oestrogen or Parathyroid hormone (PTH)) action on bone 
cells (Raggat and Partridge, 2010; Kini and Nandeesh, 2012). The signals are detected by 
osteocytes and translated into biological signals which recruit and activate osteoclast precursor 
cells from the circulation, resulting in the interaction of osteoclast and osteoblast precursor 
cells (Raisz, 1999; Raggat and Partridge, 2010; Clarke, 2008). This action leads to the 
differentiation, migration and fusion of mononuclear monocyte-macrophage osteoclast 
precursors to the bone surface where they fuse together to form multinucleated osteoclasts 
(Raisz, 1999; Kini and Nandeesh, 2012). The osteoclasts bind to bone matrix via integrin 
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receptors present on their cell membranes, upon binding they become polarised with the bone 
resorbing surface developing a ruffled border (Raisz, 1999; Clarke, 2008). 
 
Resorption phase: The resorption phase lasts approximately for 2 – 4 weeks during each 
remodelling cycle (Clarke, 2008; Kini and Nandeesh, 2012). The ruffled border of resorbing 
osteoclasts secrete hydrogen (H+)  ions via H+ - ATPase proton pumps and chloride channels 
in their cell membranes into the resorbing compartment to lower the pH to as low as 4.6. The 
low pH created by the release of H+ ions aids osteoclasts to dissolve the mineral component of 
bone (Clarke, 2008).  These cells also release lysosomal enzymes, particularly cathepsin K, to 
digest organic matrix (i.e. type I collagen)  resulting in the formation of irregular scalloped 
cavities on the trabecular bone surface, called Howship lacunae, or cylindrical haversian canals 
in cortical bone (Raisz, 1999; Clarke, 2008). The mineral salts of the bone matrix are released 
into the interstitial fluid, where they diffuse into the blood and are carried away, as are the 
peptides and amino acids of collagen fibres (Clarke, 2008).   
 
Reversal phase: Following the resorption phase is the reversal phase, wherein bone resorption 
transitions to bone formation (Clarke, 2008). At the completion of bone resorption, resorption 
cavities contain a variety of mononuclear cells such as monocytes and osteocytes which are 
released from bone matrix, and pre-osteoblasts recruited to begin new bone formation (Clarke, 
2008; Kini and Nandeesh, 2012). The events occurring during this stage are not well 
understood, but it has been proposed that they may involve further degradation of remnant 
collagen and release of growth factors to initiate the final phase (Raisz. 1999; Raggat and 
Partridge, 2010).  Pre-osteoblast recruitment involves the release of several growth factors such 
as insulin growth factor (IGF) embedded within the bone matrix.  
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Formation phase: Bone formation takes approximately 4 – 6 months to complete and involves 
osteoblasts, which originate from mesenchymal stem cells (osteoprogenitor cells) of the bone 
marrow stroma that can give rise to bone, cartilage, fat or fibrous connective tissue (Raggat 
and Partridge, 2010; Kini and Nandeesh, 2012). Osteoblasts synthesise new collagenous 
matrix, which fills the perforated area and regulate mineralisation of matrix by releasing small, 
membrane-bound vesicles that concentrate Ca2+ and PO43- (Clarke, 2008; Kini and Nandeesh, 
2012). Once the osteoblast has completed its cycle of matrix synthesis, it can become a 
flattened bone lining cell found on the surface, be buried within the matrix as an osteocyte, or 
undergo apoptosis (Raisz, 1999). Once the formation phase has been completed approximately 
50 to 70% of osteoblasts undergo apoptosis (Clarke, 2008).   
 
 
 
 
Figure 1.2 Bone remodelling is initiated when osteoclast resorb bone mineral and matrix, 
which is followed by mononuclear cells preparing the resorbed surface for osteoblasts. 
Osteoblasts synthesise new matrix and differentiate into osteocytes, which completes the 
remodelling cycle (Kapinas and Delany, 2011).  
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1.2.1 Osteoblasts  
Osteoprogenitor cells are derived from pluripotent stem cells, found in the bone marrow. 
Osteoprogenitor cells give rise to osteoblasts that are responsible for the synthesis of bone 
matrix and its subsequent mineralisation (Hadjidakis and Androulakis, 2006; Kini and 
Nandeesh, 2012). Osteoblasts are mononucleated, and depending on their cellular activity can 
either be flat or plump (Kini and Nandeesh, 2012). Osteoblasts synthesise and lay down 
collagen I, which constitutes 90-95% of the organic matrix of bone. Collagen is deposited in 
concentric layers to produce mature (lamellar) bone. However, osteoblasts deposit collagen 
rapidly in a basket-like weave resulting in woven, immature bone, commonly seen in 
conditions such as fracture callus. Osteoblasts also produce and deposit non-collagenous 
proteins, of which osteocalcin and alkaline phosphatase (ALP) are the most abundant proteins 
present in bone (Clarke, 2008; Kini and Nandeesh, 2012). The roles of each protein have yet 
to be determined, and many seem to serve multiple functions, including regulation of bone 
mineralisation and of bone cell activity. It is thought that ALP and OCN are Ca2+and PO43-
binding proteins which help ordered deposition of mineral by regulating the amount and size 
of hydroxyapatite crystals formed (Clarke, 2008). 
 
Following mineralisation of bone matrix, mature osteoblasts undergo apoptosis, revert back to 
bone lining cells or become embedded within the matrix and differentiate into osteocytes, 
which account for 90-95% of all bone cells (Raggatt and Partridge, 2010). These embedded 
cells form a network throughout mineralised bone, and maintain connection with each other 
and with osteoblasts on the bone surface via dendritic like processes that lie within the 
canaliculi (Raggatt and Partridge, 2010). They normally do not express ALP but do express 
OCN and several other matrix proteins that support intracellular adhesion and regulate 
exchange of mineral in the bone fluid within lacunae and the canalicular network.  Osteocytes 
detect stress signals from bending and stretching of bone and convert these signals into 
biological activity. Osteocytes have the ability to live within human bone that is not turned over 
for decades (Clarke, 2008).  
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1.3 Bone repair 
Bone remodelling does not only occur during bone formation but also in bone repair, where a 
bone is injured due to fracture. Despite the bone’s natural healing capacity, it is susceptible to 
fracture (Geris et al., 2009). When there is a change in external stimulus, the bone either 
remodels itself to withstand the pressure or it fractures when the energy from the impact 
exceeds the energy the bone can absorb (Turner, 2002).   
 
Following bone trauma, the cortical bone and the periosteum are damaged, rupturing numerous 
blood vessels resulting in bleeding and the formation of a clot (hematoma) enclosing the trauma 
site (Geris et al., 2009; Thompson, 2013). As a consequence of the vascular damage, the injured 
bone becomes hypoxic, affecting the osteocytes which go onto necrose with the damaged 
tissue. The necrotic process recruits the inflammatory cells, such as macrophages and 
neutrophils to the site to remove debris. This is followed by the invasion of fibroblasts which 
produce a fibrous network, soft callus (Geris et al., 2009). The soft callus is remodelled into 
cartilage forming a temporary repair called procallus, mechanically stabilising the fracture site 
(Geris et al., 2009; Steele and Bramblett, 2007). Blood vessels invade the procallus, bringing 
along osteoblasts that produce a hard callous tissue of mineralised woven bone matrix (Geris 
et al., 2009). The remodelling phase begins with osteoclastic resorption of poorly placed bone 
matrix and the formation of lamellar bone by osteoblasts (Geris et al., 2009).  
 
The success of many medical interventions has increased the lifespan of humans from an 
average of 45 years to 78 years (Hench et al., 2010). It has been estimated that by 2050 nearly 
one in five people will be over the age of 60 (Hench et al., 2010). An increased lifespan poses 
a problem as the quality of life often deteriorates due to the gradual degradation of tissue, 
including bone (Hench et al., 2000). Normal bone function is a consequence of a balance 
between bone resorption and bone formation, however this system declines with age. It has 
been observed that with increasing age, bone becomes porous, the harversian canals and 
canaliculi become plugged and the number of empty osteocyte lacunae increases. Furthermore, 
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osteoblast number and activity decreases which in effect results in decreased bone formation 
and delayed mineralisation. In addition the number of osteocytes decline with age (Kloss and 
Gassner, 2006).  The increase in bone loss is supposedly in part due to the decreased activity 
of osteoblasts and a prolongation of the lifespan of osteoclasts. An increase in bone resorption 
is prevalent in ageing women as a result of menopause, although resorption is thought to 
increase mildly in ageing men too (Clarke, 2008; Lane, 2006).  
 
Consequently, the probability of fracture of long bones, hips and collapse of vertebrate 
increases significantly (Hench et al., 2000). The consequences in treating patients with bone 
fractures has become a major health care concern, in the UK it costs £2 billion each year 
(Mitchell et al., 2010). This cost is expected to rise in the future in light of the ageing 
population. It has been estimated that each year in the UK approximately 300,000 fractures 
occur amongst the ageing population due to osteoporosis (decreased bone turnover due to 
impaired formation of osteoclasts and loss of function). High rates of morbidity and mortality 
are associated particularly with hip fractures, with fewer than half of the patients retuning home 
following surgery (Rose and Oreffo, 2002). Furthermore, it has been reported that 1,150 people 
die every month in the UK following a hip fracture (Mitchell et al., 2010).  
 
1.4 Current treatment for bone tissue repair 
Most fractures are treated by immobilising the bone with bioinert implants such as corrosion 
resistant metals (i.e. stainless steel alloys) and insoluble, non-toxic polymers (i.e. ultrahigh 
molecular weight polyethylene) (Hench et al., 2010; Bock et al., 2003). The first generation of 
bone replacement materials were selected to be as chemically inert in the body as possible (so 
not to induce an inflammatory response). These bioinert materials have enhanced the quality 
of life of millions during the last 40 years (Hench et al., 2000). However, all so-called bioinert 
materials elicit a host immune response to act against the foreign body resulting in the 
formation of a non-adherent fibrous capsule between the material and living bone, which 
isolates the implant from the host (Long, 2008; Anderson, 2001; Nuss and Rechenberg, 2008).  
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The foreign body reaction starts within seconds or minutes after tissue contact with a 
conditioning film of proteins (e.g. fibrinogen, fibronectin, immunoglobulin G) on the surface 
of the implant. This protein film initialises the recruitment and migration of monocytes and 
fibroblasts through the endothelium (Sevastianov, 1988; Nuss and Rechenberg, 2008). After 
adhesion the monocytes transform into macrophages which recruit other monocytes and 
coalesce to form foreign body giant cells (Nuss and Rechenberg, 2008; Anderson et al., 2008). 
Macrophages and foreign body giant cells ingest and dissolve implanted material intracellularly 
or by the release of degradative agents like lysosomal enzymes, and reactive oxygen 
intermediates. However, bioinert implants cannot be ingested by macrophages and foreign 
body giant cells resulting in implant isolation. Foreign body giant cells form a layer, in a fibrous 
quite avascular capsule around the implant, limiting interaction between host and the implant 
(Nuss and Rechenberg, 2008). The thickness of the fibrous capsule depends on the conditions 
of the implant (Cao and Hench, 1995).  
 
Nearly 2 million orthopaedic devices are implanted annually worldwide (Hench et al., 2000). 
In spite of this, survivability analysis demonstrates an increasing population of implants, such 
as total hip prostheses, failing before the patient dies (Hench et al., 2000). The reason for failure 
is related to the progressive deterioration of the bone in contact with the implant. As a result 
bioinert implants are a compromise because they do not form a real chemical bond with living 
tissue (Hench et al., 2010; Tilocca, 2010). Therefore, over time tissue breakdown and implant 
detachment becomes inevitable resulting in the need for revision surgery (Hench et al., 2010). 
Loosening and detachment is estimated to occur in many as 50% of cemented total-hip 
replacements. Loosening of an implant could be attributed to several biomechanical factors 
such as excessive activity by the patient, debonding at the tissue-implant interface, material 
fatigue, inflammation, infection and osteolysis (Long, 2008). 
 
However, approximately 10% of bone defects due to fractures, surgery or tumours cannot be 
treated using the conventional method, because the damaged sites are too large and also due to 
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eventual implant failure (Bock et al., 2003). Therefore, the most prevalent clinical approach is 
bone graft, which is the second most common transplantation tissue with the exception of blood 
(Giannoudis et al., 2005). More than 2.2 million bone grafting procedures are taking place 
annually worldwide in order to repair bone defects in orthopaedics and dentistry (Martin, 
2012).  
 
Autograft and allograft are the preferred choices, with autograft being the golden standard of 
bone grafting (Giannoudis et al., 2005; Moore et al., 2001). Autograft involves harvesting 
cancellous bone from the iliac crest (upper hip) due to ease of access and recovery of good 
quality cancellous bone (Martin, 2012; Giannoudis et al., 2005; Moore et al., 2001).  Autograft 
is the most effective bone graft material, because it is natural tissue that contains the progenitor 
cells and growth factors necessary for bone remodelling (Martin, 2012). However, few mature 
osteoblasts survive the transplantation process, but adequate numbers of precursor cells do 
survive resulting in bone repair (Moore et al., 2001). Unfortunately, autograft has several 
drawbacks, such as increased operative time, donor site morbidity related to blood loss, wound 
complications, and most importantly chronic pain (Moore et al., 2001; El-Ghannam et al., 
1995).  
 
Allograft bone is obtained from cadaver sources and is regarded as a surgeon’s second choice, 
as it offers the same characteristics as autograft with the exclusion of osteogenic cells (Moore 
et al., 2001; Giannoudis et al., 2005; Nandi et al., 2010). Allograft use permits the avoidance 
of morbidity associated with autograft harvesting and is of particular importance when 
inadequate volume of autograft is available for large defects (Moore et al., 2001). Allograft 
bone is implanted up to 300,000 times worldwide, which is 100 times more than heart 
transplantations and 25 times more than kidney transplantations (Zimmermann and 
Moghaddam, 2011). Despite its increasing availability the complications associated with 
allograft include fracture and infection. Fracture rates of up to 19% associated with allograft 
use have been reported. Furthermore bacterial infection is more common, especially with 
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increased sized grafts and may be seen in more than 10% of massive allografts (Moore et al., 
2001). In addition, viral transmission is also a potential risk and to prevent this from occurring 
allograft tissue is processed, which lowers the risk but significantly reduces the initial 
mechanical and biological properties present in the bone tissue (Moore et al., 2001; Giannoudis 
et al., 2005). These limitations surrounding the biological grafts have directed attention towards 
the use of synthetic bone graft materials, such as Ca2+ and PO43- ceramics. They have an 
excellent record of biocompatibility; also no systemic toxicity has been reported with minimal 
foreign body reactions (Moore et al., 2005; Giannoudis et al., 2005). Shortly after implantation 
a layer of carbonated hydroxyapatite (HCA) forms that is responsible for the bond observed 
between the graft and bone tissue, inducing bone remodelling (Moore et al., 2005). The Ca2+ 
and PO43- ions required for this action are derived from the implant and the surrounding bone 
(Moore et al., 2005).  
 
Dense and porous hydroxyapatite (HA), which forms the mineral component of bone, and 
tricalcium phosphate (TCP) ceramics are the materials most widely used (El-Ghannam et al., 
1995; Martin, 2010). Synthetic HA has been successfully used to coat bioinert implants, and 
as a porous granular form with bone graft to fill bone defects, as it supports the growth of bone 
on its surface (Moore et al., 2005). One of the main drawbacks of synthetic HA is that it is 
poorly resorbed in vivo, and due to this the rate of bone formation is slow (El-Ghannam et al., 
1995; Moore et al., 2005). Additionally the particulates that are at a distance from the defect 
will become encapsulated by fibrous tissue (El-Ghannam et al., 1995). TCP is more 
bioresorbable than synthetic HA, it is removed from the implant site as bone grows into the 
scaffold whereas HA is more permanent (Giannoudis et al., 2005). Furthermore, the porosity 
of TCP allows resorption via dissolution and fragmentation over a 6-18 month period, and 
infiltration by bone forming cells and nutrients for bone recovery (Giannoudis et al., 2005). 
The solubility of TCP is higher than the rate of tissue regeneration, there is always less bone 
volume produced than the volume of TCP reabsorbed (Giannoudis et al., 2005). This is a major 
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setback hence why TCP is used as an adjunctive with other less resorbable materials (such as 
HA) or as an expander for autograft (Giannoudis et al., 2005; Martin, 2012).  
 
1.5 Bioactive glasses 
A bioactive material is a material that elicits a specific biological response at the material 
surface, which results in the formation of a bond between the tissues and the materials 
(Gerhardt and Boccaccini, 2010). Two classes of bioactive materials have been recognised,  
Class A and Class B.  
 
Class A bioactive materials have the following characteristics (Cao & Hench. 1995; Hench et 
al., 2000; Hench. 2006; Hench et al., 2010):  
1. The material forms a bond to both bone and soft connective tissues. 
2. The material is osteoproductive, which means colonisation and proliferation of bone 
distant from the implantation site. 
3. The material is osteoconductive, the ability to support the growth of bone over its 
surface (Moore et al., 2001). 
4. The material resorbs as new bone replaces it.  
 
The characteristics of Class B bioactive materials include (Cao & Hench. 1995; Hench et al., 
2000):  
1. The material bonds to bone but not soft tissues. 
2. The material is not osteoproductive. 
3. The material is osteoconductive. 
4. The material resorbs very slowly and may not be in contact with newly formed bone.  
 
Bioactive glasses (BAGs) are one of the most promising synthetic materials for bone repair, 
replacement, and regeneration because they have the potential to be more bioactive than 
calcium phosphate based materials (Martin, 2012). They are an example of class A bioactive 
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materials whereas calcium phosphates (i.e. synthetic HA) are an example of class B bioactive 
materials. Oonishi et al. (1997) reported that Bioglass® allowed full bone restoration in 2 weeks, 
whereas synthetic HA following implantation needed 12 weeks to produce comparable results. 
 
The first BAG was invented in 1969 by Larry Hench following a conversation with a US Army 
colonel who queried if a material could be developed that was able to survive the conditions of 
the human body. Larry Hench then set out to develop a material which would not form a fibrous 
encapsulation but instead a living bond with the host tissue. He went on to develop several 
compositions all based around the Na2O-CaO-SiO2-P2O5 glass system. However, the 
composition selected was that of 46.1 mol % SiO2, 24 mol% Na2O, 26.9 mol% CaO and 2.6 
mol% P2O5 which was later termed 45S5 Bioglass® (Jones, 2013).  This composition was 
successful due to the strong bond formed in vivo between 45S5 Bioglass® and rat bone, it was 
noted that 45S5 Bioglass® could not be removed without breaking the bone (Hench. 2006; 
Jones, 2013). Following the discovery of 45S5 Bioglass® the field of bioactive ceramics was 
established, with many new materials formed including various compositions of bioactive 
glasses, calcium phosphate ceramics such as synthetic hydroxyapatite and other composites 
(Hench et al., 2010; Jones, 2013). However, bioactive glasses remain popular because they 
allow control of a range of chemical properties and the rate of bonding to different tissues 
(Hench, 2006). 
 
Since its discovery, 45S5 Bioglass® has shown great success in many clinical applications 
particularly in the dental and orthopaedic fields (Abou Neel et al., 2009). In 1984 it was used 
as middle ear prostheses (MEP®) to restore the ossicular chain and treat conductive hearing 
loss. The second commercial device was the Endosseous Ridge Maintenance Implant (ERMI®) 
in 1988, used to preserve the alveolar ridge from the bone resorption that follows tooth 
extraction (Jones, 2013; Hench. 2002). However, neither of these products is in widespread 
clinical use, due to their fixed size and shape. The lack of successfulness of monolithic shapes 
led to particulate use (Jones, 2013). In 1993 the first 45S5 Bioglass® particulate product was 
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produced, PerioGlas® was used to repair defects in the jaw that resulted from periodontal 
disease (Hench, 2006). Following the success of PerioGlas® in dental bone regeneration, the 
product NovaBone® was manufactured for orthopaedic bone grafting in 1999, though it was 
not available for clinical use until 2000 for non-load bearing sites. More recently, 45S5 
Bioglass® particulates (NovaMin®) have been used in toothpastes for treating tooth 
hypersensitivity, which affects 35% of the population of US and similarly in Europe (Hench, 
2006). 45S5 Bioglass® is not the only bioactive glass in clinical use, BioGran® is another 
synthetic bone graft used in jaw bone defect regeneration, which has a similar composition but 
a narrower particle size range (Jones, 2013).  There are now several types of BAGs, the 
traditional silicates, which include the 45S5 Bioglass®, phosphate-based glasses and borate-
based glasses. Various compositions are constantly being designed and investigated for 
potential clinical use within many fields.  
 
1.5.1 Structure of bioactive glasses 
A glass is a network of atoms (mostly silicon) bonded together via covalent bonds with oxygen 
atoms. The base components of most BAGs are SiO2, Na2O, CaO and P2O5. Silicate based 
glasses are composed of silica tetrahedral (SiO4) that are connected to each other by oxygen 
atoms (- Si – O – Si -). The role of silicon (SiO4) is that of a network former which maintains 
the glass structure (Hench et al., 1971; Jones, 2013). Sodium (Na+) and Ca2+ ions are added to 
the glass system because they make it easier to melt the glass, and secondly they dissolve from 
the glass and modify the local pH (Hench et al., 1971). But most importantly they disrupt the 
network by forming non-bridging oxygen bonds, whereby some of the oxygen atoms are no 
longer bonded to two silicon atoms, forming bonds such as Si – O- + Na, and are therefore 
network modifiers (Jones and Clare, 2012) (Figure 1.3).   
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Figure 1.3 (A) two-dimensional presentation of the structure of crystalline SiO2. (B) Two-
dimensional presentation of glass SiO2. (C) Two-dimensional presentation of a glass network 
composed of network modifiers and network formers.  
 
The silica content determines the solubility of the glass (Figure 1.4). If the silica content is high 
(> 60 mol%), a highly connected network with a large proportion of bridging oxygen bonds is 
formed, resulting in low dissolution and low bioactivity. This is true of traditional soda-lime-
silica glass systems, which consist of more than 65 mol% SiO2 and therefore fail to undergo 
reactions with body fluids (Jones and Clare, 2012). Connectivity is lowered when the silica 
content is less than 60 mol%, and by the addition of network modifiers such as Ca2+ and Na+. 
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It was presumed that P2O5 was also required for a glass to be bioactive. However, later on it 
became known that phosphate played a role in nucleation of the calcium phosphate phase that 
occurred on glass surface (Jones, 2013). It is believed that phosphate is not an important 
constituent since the surface can adsorb PO43- ions from solution (Jones and Clare, 2012). 
 
 
Figure 1.4 Bioactivity map of BAGs in the SiO2 – Na2O – CaO system (2.6 mol% of P2O5) 
showing regions of bioactive response (Jones and Clare et al., 2012; Hench). Bioactive glass 
compositions in region A bond to bone, whilst those in region B are effectively bio-inert and 
become encapsulated in scar tissue. This is due to the silica content being too dense and 
resistant to reaction with body fluid. Glass systems in region C degrade too rapidly, as the silica 
content is too low and the soda content too high, resulting in a highly disrupted network. Region 
D contains BAGs with such low silica that a glass network cannot form. Bioactive glasses 
within regions A and E strongly form bonds with collagenous (soft) tissue and with the 
inorganic part of the bone. 45S5 Bioglass falls within regions A and E. (Jones and Clare, 2012). 
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1.5.2 The bioactivity of bioactive glasses 
The ability of BAG to bond to bone and stimulate new bone growth is attributed to the 
formation of a HCA layer, which interacts with collagen fibrils of damaged bone to form a 
bond. The process for HCA layer formation is relatively well understood, however the 
biological interactions occurring at the HCA – host bone interface are poorly understood 
(Jones, 2013). Nevertheless, Hench and his co-workers have revealed that 11 reaction stages 
are involved in bone regeneration, which occur at the BAG surface (Hench et al., 2003; Hench 
et al., 2010). 
The first five reaction stages involve the rapid release (within 2-24 hours) of soluble ionic 
species from the BAG into the interfacial solution, and the formation of a high surface area 
hydrated silica and polycrystalline HCA layer on the BAG surface (Martin, 2012; Jones, 2013).  
 
1. Rapid ion exchange of cations, Na+ or  Ca2+ ions from the BAG surface with 
(hydrogen) H+ ions from solution, creating silanol bonds (Si – OH) on the glass surface: 
Si – O – Na+  + H2O             Si – OH- + Na+ (aq) + OH- 
pH of the solution increases and a silica rich (cation-depleted) region forms near the 
glass surface. If P is present in the composition it is also lost from the glass. 
 
2. OH- ions attack the silica network of the glass, by breaking the Si – O – Si bonds. 
Soluble silica is released in the form on Si(OH)4 into the solution, leaving more silanol 
groups at the glass – solution interface:  
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3. Condensation of the silanol groups near the glass surface resulting in the 
repolymerisation of the silica rich layer.  
 
4. Migration of Ca2+ and PO43- groups to the surface through the silica-rich layer and from 
the solution, forming a film rich in amorphous CaO –P2O5 on the silica rich layer.  
 
5. Incorporation of hydroxyls and carbonate from the surrounding solution and 
crystallisation of the CaO – P2O5 film to form HCA layer.  
 
Once the HCA layer has formed, the next stages are less clear, as the exact mechanism is 
difficult to elucidate.  
 
6. Macrophages are recruited as a response to the damage caused by implantation. 
However, they do not react to the glass, and therefore do not remain at the site of defect 
for very long. They do not evolve into foreign body giant cells in an effort to digest the 
material 
 
7. Progenitor cells of the osteoblast lineage attach rapidly on to the HCA surface during 
the first 24-48 hours.  
 
8. The osteoprogenitor cells on the HCA surface begin to proliferate. 
 
9. The cells differentiate into the osteoblast phenotype; this occurs rapidly on the surface 
of BAGs, whereas it takes several weeks for similar cellular events to occur on the 
surface of bioinert materials. In contrast, osteoprogenitor cells colonise the surface of 
bioactive materials within 24-48 hours. 
 
10. The new osteoblasts that colonise the surface begin to produce extracellular matrix, 
and induce nucleation of the HCA bone mineral. 
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11. HCA mineralisation continues until the osteoblasts are completely embedded in 
mineralised extracellular matrix. The result is new bone formation. 
 
1.5.3 Control of osteoblast cell cycle 
The formation of the biologically active surface HCA layer, lays down the foundation for 
chemical events which lead to bone regeneration (Gerhardt and Boccaccini, 2010; Hench et al., 
2010; Hoppe et al., 2011). The key mechanism is the controlled release of ionic dissolution 
products from the degrading BAG, especially critical concentrations of soluble Si4+and Ca2+ 
ions (Gerhardt and Boccaccini, 2010; Hench et al., 2010).  For the formation of new bone, 
osteoprogenitor cells need to undergo mitosis. However, there are very few osteoprogenitor 
cells in the bones of older people that are capable of dividing and forming new bone. Therefore, 
cells that are present must receive the correct chemical stimuli from their local environment 
instructing them to enter the cell cycle (Hench et al., 2003; Hench et al., 2010).  
 
Studies have shown that 45S5 Bioglass® promotes human osteoblast proliferation by limiting 
the amount of time the cell spends in G1 (where it grows and carries out normal metabolism) 
and the S phase (DNA synthesis) of the cell cycle and then prompting its quick entry into the 
G2/M phase, when the cell is ready to undergo mitosis (Gerhardt and Boccaccini., 2010). Xynos 
et al. (2000) showed that within 48 hours in the presence of critical concentrations of soluble 
Si4+ (17-20 ppm) and Ca2+ (88-100 ppm) ions, there is a 100% increase-fold in osteoblasts in 
the S phase (Gerhardt and Boccaccini, 2010; Hench et al., 2003; Xynos et al., 2000). 
Furthermore, the percentage of osteoblasts in the G2/M phase on 45S5 Bioglass® was 
significantly higher in comparison to osteoblasts on the control (polystyrene) substrate on days 
2 and 12 (Hench et al., 2003; Xynos et al., 2000).  
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Other studies also conducted by Xynos et al. (2000) have shown that the osteoblast cell cycle 
is under genetic control. Within a few hours, exposure of human primary osteoblasts to the 
dissolution products of 45S5 Bioglass® results in the activation of several families of genes, 
including those encoding transcription factors and potent growth factors such as, the insulin-
growth factor (IGF) ll with IGF-binding proteins and proteinases that cleave IGF-ll from their 
binding proteins (Hench et al., 2003; Hench 2006). IGF-ll is the most abundant growth factor 
in bone, which is produced locally by bone cells and is considered to have autocrine and/or 
paracrine effect (Hench et al., 2003; Xynos et al 2000). Xynos et al (2000) cDNA microarray 
analysis showed a 320% increase in the expression of IGF ll in osteoblasts that were exposed 
to bioactive glass. The results show that 45S5 Bioglass® may increase the availability of IGF-
ll in osteoblasts by stimulating the transcription of IGF-ll and its binding protein and also by 
regulating its dissociation from the binding protein (Hench et al., 2003; Hench 2006). 
Consequently the unbound IGF-ll is likely to be responsible for increased cell proliferation 
seen in culture (Hench et al., 2003; Hench 2006).  
 
Not only does the cell cycle induce cell proliferation but to some extent it also determines cell 
commitment and differentiation (Hench, 2006). Osteoblast differentiation has been 
investigated by measuring ALP activity and OCN synthesis (Xynos et al., 2000). ALP is a cell 
membrane associated enzyme, which regulates phosphate metabolism and locally down-
regulates inhibitors of apatite crystal growth (Kini and Nandeesh, 2012,). It is a marker that 
appears early during osteoblast differentiation but both its expression and activity diminish 
with the onset of mineralisation (Kini and Nandeesh, 2012). OCN is a non-collagenous matrix 
protein with a high affinity for Ca2+, which is also known to inhibit apatite crystal growth both 
in vitro and in vivo (Clarke, 2008). OCN is thought to be a marker which appears late during 
osteoblast differentiation and characterises osteocytes (terminally differentiated osteoblasts), 
which are post-mitotic and incapable of cell division (Hench 2006; Kini and Nandeesh, 2012). 
Xynos et al. (2000) have shown osteoblast ALP activity to be markedly increased on day 6 of 
culture when grown on bioactive glass, but declined by day 12 to levels significantly less than 
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in control cultures. Likewise, OCN synthesis was significantly higher in osteoblast cultures 
grown on the bioactive substrate in comparison to those grown on control substrate following 
6 days in culture. These findings indicate that BAG has the ability to stimulate the development 
of a mature osteoblast phenotype (Xynos et al., 2000).  
 
The studies reported above investigated the osteogenic properties of 45S5 Bioglass® and have 
shown promising results. Nonetheless numerous research groups have fabricated and 
investigated other BAG compositions which have also influenced osteoblast proliferation and 
differentiation. The 58S (60 mol% SiO2, 36 mol% CaO and 4 mol% P2O5) BAG dissolution 
products stimulated the proliferation of osteoblast cells and upregulated the expression of many 
genes including ALP, OCN and the extracellular matrix protein collagen I (Christodoulou et 
al., 2004). In addition 60S BAG (59.9 mol% SiO2, 38.4 mol% CaO and 1.74 mol% P2O5) 
showed a 50% increase in osteoblast proliferation and increased collagen I production (Valerio 
et al., 2003). 47S (47 mol% SiO2, 26 mol% CaO, 21 mol% Na2O and 6 mol% P2O5) highlighted 
the biocompatibility of this glass as it enhanced osteoblast proliferation in culture (Mohamed 
et al., 2008). Mesenchymal stem cells are capable of skeletal repair and regeneration due to 
their ability to differentiate into osteoblasts. This ability is important for successful 
osteointergration of implanted materials. Bosetti and Cannas. (2004) reported that a significant 
effect of 45S5 Bioglass® and 77S (80 mol% SiO2, 16 mol% CaO, 4 mol% P2O5) BAG was 
observed on early differentiation of mesenchymal stem cells into osteoblast cells. Additionally, 
Radin et al. (2005) and Reilly et al. (2007) reported similar findings, 45S5 Bioglass® cultured 
with mesenchymal stem cells elevated ALP activity. Furthermore, in order to enhance the 
bioactivity of BAGs towards desired biological responses glass systems have been doped with 
metal ions such as strontium (Sr2+), magnesium (Mg2+), and copper (Cu2+) (Gentleman et al., 
2010; Tousi et al., 2013).  
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1.5.4 Antibacterial properties 
Lack of tissue integration is not the only factor that compromises the integrity of current bone 
implants, as infection also plays a major role in implant failure. It has been reported that 
approximately 50% of the 2 million nosocomial infections that occur annually are implant 
related (Mortazavi et al., 2010). Although the infection rate following implantation of 
orthopaedic devices has decreased in the past 50 years the number of older patients requiring 
replacement surgery is steadily increasing, and thus the number of patients with implant related 
infections are rising (Zimmerli and Ochsner, 2003). Implant related infections are associated 
with high complications, particularly in the elderly who are susceptible to infection due to 
immunosenescence, poor nutrition, and multiple commodities and impaired wound healing. 
Furthermore, these infections have considerable repercussions for the healthcare system with 
long hospital stay and increased morbidity and mortality (Mortzavi et al., 2010; McGarry et 
al., 2004). The mortality rate due to surgical intervention for implant infections has been 
estimated to be 0.4%-1.2% for 65 year old patients and 2%-7% for 80 year old patients 
(Lentino, 2003).  
 
Implant devices can become colonised by bacteria at the time of surgery or via a 
haematogenous route from a distant source (Long, 2008; Schierholz and Beuth, 2001). The 
current bioinert implants are susceptible to microbial adhesion, which may colonise the implant 
surface and thus lead to inflammation at the implantation site. Infections at the site of 
implantation occur at a frequency of up to 4.3% and in the case of revision surgery up to 17% 
(Moseke et al., 2011). Implant related infections are related to the highly adaptive ability of 
bacteria to colonise the surfaces of inert implants or of adjacent, damaged tissue cells (Gristina, 
1987). Many implants are composed of one or more metals or polymers and are inanimate in a 
biological environment and thus do not resist infection (Gristina, 1987). Despite their inertness, 
most implant surfaces are physiocochemically active and modulate events such as cellular 
adhesion and integration, and inflammatory and immunomodulating responses (Gristina, 1987; 
Schierholz and Beuth. 2001).  Furthermore, implant surfaces adsorb host extracellular matrix 
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proteins such as fibronectin, fibrinogen, elastin and collagen and thus provide receptor sites for 
bacterial adhesion (Gristina, 1987; Hudson et al., 1999). Several microbial species possess 
adhesins which mediate cell anchorage and fixation to host extracellular proteins (Compoccia 
et al., 2006). For instance Staphylococcus aureus has discrete binding sites for extracellular 
matrix proteins, collagen and fibronectin (Gristina, 1987; Schierholz and Beuth. 2001). The 
family of adhesins not only facilitate adhesion to orthopaedic implants but also to bone matrix 
(Hudson et al., 1999). 
 
The most recovered isolates from infected implant surfaces are Gram-positive S. aureus and 
Staphylococcus epidermidis (Gristina, 1987; Arciola et al., 2005; Cordero et al., 1996). 
Additional microorganisms isolated include Escherichia coli, Pseudomonas aeruginosa, 
Proteus mirabilis, and beta haemolytic Streptococcus (Gristina, 1987; Arciola et al., 2005). 
However, a very large proportion of implant related infections occur due to S. aureus and S. 
epidermidis as infections caused by other pathogenic microbial species represent only a 
minority of implant related infections, approximately about 22% (Campoccia et al., 2006). The 
success of S. aureus in part is due to the alarming level of antibiotic resistance it exhibits, as 
four out five strains do not respond to penicillin drugs, whereas methicillin/oxacillin resistance 
is observed in four out of ten strains (Campoccia et al., 2006). Moreover, S. aureus possesses 
the ability to form biofilms on implant surfaces. Within the biofilm, bacteria can persist in a 
low metabolic, stationary growth phase, in which they resist the action of host immune system 
and antibiotics (Baldoni et al., 2010). 
 
Antibiotic resistance and systemic toxicity with associated renal and liver complications render 
antibiotics ineffective in preventing implant-related infections (Ahmed et al., 2006; Mulligan 
et al., 2002). Therefore, good medical management dictates removal of colonised or infected 
devices (Long, 2008). Both the spread of antibiotic resistance and the increased use of implants, 
warrant the need for new and innovative therapeutic strategies. Bioactive glasses could be the 
ideal implants because not only do they promote regeneration of living tissue but they have 
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also been shown to exhibit antibacterial activity when used as therapeutic materials (Munukka 
et al., 2007; Mortazavi et al., 2009). Furthermore, they could provide a sustained delivery of 
antibacterial ions to the local microenvironment. 
 
There are numerous experiments in vitro which show silicate-based BAGs to display a broad 
and certain antibacterial effect against various pathogenic bacteria. 45S5 Bioglass® was the 
first silicate-based BAG to be composed and it was shown to reduce microbial infections when 
it was used to repair periodontal defects, which are prone to infection following surgery with 
bioinert materials. Based on these findings Stoor et al. (1998) set out to prove that BAGs were 
antibacterial, and in 1998, through experiment in vitro they demonstrated that the bioactive 
glass S53P4 (53 mol% SiO2, 20 mol% CaO, 23 mol% Na2O, 4 mol% P2O5) had a broad 
antibacterial effect on oral bacteria in the planktonic phase (Stoor et al., 1998). Thereafter, 
many authors including Allan et al. (2000) found BAGs to exhibit a similar antibacterial effect 
against certain oral bacteria.  
 
Since then in vitro studies have been conducted to determine whether BAGs exerted a similar 
antibacterial effect on skin pathogenic bacteria. Initial antibacterial studies revealed that the 
antibacterial activity of BAGs was attributed to the high pH levels caused by the release of 
alkali ions from BAG particles (Hu et al., 2009). When BAGs are immersed into an aqueous 
environment they undergo a series of surface reactions resulting in the release of soluble Na+ 
and Ca2+ ions, which increase the aqueous pH value (Munukka et al., 2007; Hu et al., 2009). 
However, the mechanisms of antibacterial activity remained unknown and are still not clearly 
understood, but several theories have been proposed.  
 
Elevated pH can alter the pH gradient of the bacterial cytoplasmic membrane, which is required 
for the movement of organic nutrients and components into the cell (Xie et al., 2008). As a 
result the permeability of the cytoplasmic membrane is compromised and the bacteria 
eventually succumb to death due to increased toxicity. Another theory is that hydroxyl (OH-) 
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ions can react with fatty acids in the membrane to form free lipid radicals which weaken the 
bacterial membrane structure causing it to collapse (Xie et al., 2008).  Ion concentrations and 
changes in osmotic pressure may also play a role in the antibacterial action of BAGs. The 
release of ions from BAGs cause a rise in the salt concentration creating an osmotic pressure 
that would be inhibitory to most bacteria.  
 
Allan et al. (2000) emphasised the important role the pH plays in inhibiting oral bacterial 
growth. They found that the antibacterial activity between Bioglass® supernates and media 
adjusted with sodium hydroxide to the same pH, demonstrated similar antibacterial activity 
against certain oral bacteria (Allan et al., 2000). Furthermore, Hu et al. (2009) and Mortazavi 
et al. (2009) conducted antibacterial studies on skin pathogens, the results of which highlighted 
the importance of pH. In the study conducted by Hu et al. (2009) the pH value for the media 
without 45S5 Bioglass® particles was 7.0 and the bactericidal percentage was below 10%. By 
contrast the bactericidal percentages for S. aureus, S. epidermidis and E. coli increased up to 
98% when tested against the 50 mg/ml concentration, the pH value for which was 9.8 (Hu et 
al., 2008). Likewise, Mortazavi et al. (2009) also demonstrated the importance of high pH 
levels, the initial pH value of the broth was measured at 7.3 but following the addition of 58S 
(60 mol% SiO2, 36 mol% CaO, 4 mol% P2O5) nanoparticles the pH value was 8.3, which 
resulted in sparse E. coli growth and moderate growth for S. aureus (Mortazavi et al., 2009). 
These results confirm that a high pH value is a critical factor in BAG antibacterial activity. 
However, Munukka et al. (2008) showed that the BAG with a high CaO content (42.3 mol%) 
had a greater antibacterial effect on aerobic bacteria than BAG with lower amounts of CaO 
(31.27 mol%). They postulated that the high concentration of Ca2+ ions may have inhibited 
bacterial growth by providing a hyperosmotic environment and caused perturbations in the 
membrane potential.  
 
On the contrary, Bellantone et al. (2002) have demonstrated that BAGs do not possess either 
bacteriostatic or bactericidal activity. They found no significant difference between the mean 
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cell viabilities for control cultures and for those containing 45S5 Bioglass®, when tested against 
S. aureus, E. coli and P. aeruginosa. Results obtained from the Bellantone et al. (2002) study, 
are in agreement with Stoor et al. (1996), who reported that BAGs are not antibacterial and 
may only be subject to bacterial adhesion. A large number of in vitro studies show that BAGs 
possess antibacterial properties but one particular in vivo study conducted by Xie et al. (2008) 
contradicts such findings. They investigated the efficacy of 45S5 Bioglass® in reducing the rate 
of infection with S. aureus in open fractures in male rabbits. The culture results showed no 
significant difference between the rates of infection in the control group and in the Bioglass® 
group. These results indicate that particulate 45S5 Bioglass® may have no antibacterial activity 
in vivo. This may be due to the big buffer system in body fluid which exchanges alkali ions 
released from the 45S5 Bioglass® with nearby blood and other body fluid, and as a result the 
ionic concentration and pH at the site of implantation cannot increase to the levels required for 
bacterial growth inhibition (Xie et al., 2008). 
 
Although, BAGs have been found to exert an antibacterial effect on a range of pathogenic 
bacteria in vitro, the addition of antibacterial metal ions within the glass system have also 
demonstrated antibacterial efficacy. Most research in this field has been done by developing 
Silver (Ag+) ion doped BAGs which have shown promising results (Ahmed et al., 2006; 
Valappil et al., 2007; Pratten et al., 2004; Bellantone et al., 2002).  Copper ion doped 
phosphate-based glasses have also shown to inhibit bacterial growth (Mulligan et al., 2002; 
Abou Neel et al., 2005). Bioactive glasses could potentially be used to deliver antibacterial 
ions to prevent possible bacterial colonisation of implants following surgery and thus 
preventing poor tissue integration.   
 
1.6 Biological properties of Gallium  
Gallium (Ga3+) was discovered in 1875 by the French chemist P.E.F. Lecoq de Boisbaudran 
(Bonchi et al., 2014).  Ga3+ is a group IIIa metal, and is present at a concentration of 5 – 15 
mg/kg in the earth’s crust and is obtained as a by-product from the extraction of aluminium and 
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zinc ores (Chitamber, 2010). More than 95% of Ga3+ consumed is utilised in the electronics 
industry for optoelectronic devices and integrated in circuits (Collery et al., 2002; Chitamber, 
2010). Although, Ga3+ has no known physiological properties in the human body, it does 
however possess biological properties. In the 1970s the role of Ga3+ in living organisms was 
demonstrated by using radioactive 67Ga in medical imaging to detect and locate tumour sites 
(Lessa et al., 2012; Bonchi et al., 2014).  Over the past few decades, 67Ga scanning has been 
used to detect residual disease or disease that has relapsed following conventional therapy in 
patients with Hodgkin’s and non-Hodgkin’s lymphoma (Chitamber, 2010). This phenomenon 
propelled investigations into the therapeutic applications of Ga3+.   
 
1.6.1 Antineoplastic properties 
The ability of Ga3+ to localise in tumour cells led researchers to investigate the antineoplastic 
activity of Ga3+ compounds. Based on its clinical efficacy, gallium nitrate proved to be highly 
effective in the treatment of non – Hodgkin’s lymphoma and bladder cancer. Studies revealed 
that 30% of patients with relapsed lymphomas responded to treatment with Ga3+ nitrate. 
Although, the initial studies were conducted to investigate the antineoplastic activity of Ga3+, 
the studies also revealed that patients being treated with Ga3+ nitrate showed significant 
decrease in blood calcium levels (Chitamber, 2010). Furthermore, Ga3+ nitrate was shown to 
inhibit increased bone turnover and to decrease osteolysis (active resorption of bone matrix by 
osteoclasts) in patients with bone metastases from a variety of different cancers and metabolic 
bone diseases (Chitamber; 2010; Warrell, et al., 1984; Warrell, 1997). After extensive clinical 
studies the Food and Drug Administration (FDA) approved Ga3+ nitrate to be used (Ganite™) 
as a treatment for cancer-associated hypercalcaemia.  
 
1.6.1.1 Mechanisms of action 
Since the chemical properties of Ga3+ are similar to those of Fe3+ many biological systems 
cannot distinguish between these two metals (Bonchi et al., 2014). This similarity allows Ga3+ 
to interact with cellular processes and important proteins, especially those involved in iron 
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metabolism in mammalian and bacterial cells. In vivo studies using 67Ga have revealed that 
almost all Ga3+ in plasma is bound to the iron-transport protein transferrin (Tf) (Lessa et al., 
2012; Bonchi et al., 2014). The complexes formed with Tf are almost as stable as those formed 
with Fe3+. Gallium not only binds to Tf but also to lactoferrin, which can remove it from Tf, 
and it can also bind to ferritin. Gallium accumulates in tissues expressing high levels of Tf 
receptor (TfR), lactoferrin and ferritin receptors (Lessa et al., 2012). 
 
Gallium locates in proliferating tissue, including most tumours that express large amounts of 
TfR and it is due to this feature that tumour cells are rendered susceptible to Ga3+ cytotoxicity. 
Gallium enters the cells via endocytosis and once inside it perturbs cellular Fe3+ metabolism by 
interfering with the uptake of Fe3+ via the TfR and also with the endosomal release of Fe3+ from 
Tf to the cytoplasm (Collery et al., 2002; Chitamber, 2010). This action deprives the cell of 
Fe3+ which affects the function of the iron-dependent enzyme ribonucleotide reductase, which 
catalyses the reduction of ribonucleotides into deoxyribonucleotides during DNA synthesis 
(Collery et al., 2002; Lessa et al., 2012). Chitamber (2010) determined that the inhibitory effect 
was exerted through an interaction with the R2 sub-unit of the enzyme that contains a binuclear 
iron centre essential for enzyme activity. This interaction limits iron availability for R2 activity 
thus blocking ribonucleotide reductase activity and DNA synthesis. Therefore, Ga3+ has a dual 
action, as it blocks the availability of Fe3+ to ribonucleotide reductase and directly inhibits the 
enzyme.  
 
The iron-mimicking properties of Ga3+ may not solely be responsible for its antineoplastic 
activity as additional mechanisms could also be involved. In vitro studies have shown that the 
presence of Ga3+ induces structural changes in DNA. When low concentrations of Ga3+ ions are 
present, Ga3+ binds to DNA phosphate forming a stable complex, whereas, at higher 
concentrations bonds appear between Ga3+ and nucleic bases, resulting in DNA destabilisation 
(Collery et al., 2002). However, the association of these interactions with Ga3+ antineoplastic 
activity remain to be determined. Gallium does not only affect DNA synthesis and/or structure 
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but has also been reported to affect mitochondrial function. Ga3+ induces an efflux of Ca2+ from 
mitochondria, which is a necessary step in apoptosis. It has been suggested that the mechanism 
of action of Ga3+ may be targeted towards the mitochondrial membrane pore (Collery et al., 
2002).   
 
1.6.2 Effects on bone 
Animal and clinical investigations into the biological activities of Ga3+ revealed the tendency 
of Ga3+ to concentrate in bone. Following administration bone can accumulate large amounts 
of Ga3+, particularly in those regions where active, bone cell metabolism and thus bone matrix 
turnover are occurring (i.e. the endosteal and periosteal surfaces of bone) and it is also 
concentrated in regions of fracture healing (Bockman et al., 1990; Bernstein, 1998; Bernstein, 
2013). However, the mechanisms of Ga3+ accumulation are largely unknown. Accumulation of 
Ga3+ decreases the solubility of hydroxyapatite and renders bone more resistant to resorption 
(Bockman et al., 1990). Furthermore, significant increases in bone calcium and phosphate 
content are observed in Ga3+ treated bone which also makes bone less likely to be resorbed 
(Chitamber, 2010). Repo et al. (1988) found that rat bone treated with Ga3+ nitrate was less 
soluble in acetate buffer and less readily resorbed by monocytes. 
 
Additionally, Ga3+ prevents excessive bone resorption by blocking osteoclast activity without 
being toxic to the osteoclasts, whereas the antiresorptive activity of current therapeutic agents 
(e.g. bisphosphonates) involves toxicity to osteoclasts. Gallium produced a concentration-
dependent inhibition of osteoclast resorption activity when cultured onto the surface of dentin 
slices (Verron et al., 2010). Mills et al. (1988) reported that 67Ga citrate almost exclusively 
localised in the nuclei of osteoclasts however the significance of this localisation remains 
unclear, but indicates the potential of Ga3+ to affect gene expression and protein synthesis in 
these cells. Verron et al. (2010) demonstrated that Ga3+ can affect not only osteoclastic 
resorption but also the formation and differentiation of osteoclasts, as a marked reduction was 
observed in the expression level of transcripts coding for specific osteoclastic markers. In 
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addition, to acting directly on osteoclasts and preventing bone resorption, Ga3+ can also 
stimulate bone formation through the action on osteoblasts (Bernstein, 1998). In vitro studies 
have investigated the effects of Ga3+ on rat osteogenic sarcoma osteoblast like cells and normal 
rat osteoblasts. These studies found that Ga3+ markedly increased type I collagen (a marker for 
bone matrix formation) expression whilst vitamin D3-stimulated OCN mRNA levels were 
reduced (Guidon et al., 1993; Jenis et al., 1993; Bockman et al., 1993). Contradictory to these 
earlier findings, Verron et al., (2010) found that Ga3+ did not affect the activity or viability of 
primary mouse and MC3T3-E1 osteoblasts (non-transformed cell line established from 
newborn mouse calvaria).  
 
1.6.3 Antibacterial properties 
The first investigation on the antibacterial action of Ga3+ was reported in 1931, when Ga3+ 
tartrate was shown to eradicate experimental syphilis in rabbits. However, despite the efficacy 
and lack of toxicity of Ga3+ at high doses, the antibacterial properties of Ga3+ were overlooked 
due to the advent of antibiotics (Bonchi et al., 2014; Lessa et al., 2012). The ability of Ga3+ to 
interfere with the uptake and utilisation of Fe3+ by tumour cells launched investigations in the 
1970s to explore whether Ga3+ was able to reproduce similar effects in microorganisms.  
 
Due to its ability to interfere with Fe3+ metabolism in microorganisms, Ga3+ has been 
extensively investigated as a potential antibacterial agent (Lessa et al., 2012). Gallium 
compounds have been assayed against several Gram-positive and Gram-negative species. 
Gallium nitrate was found to inhibit growth of Mycobacterium tuberculosis and M. avium 
complex extracellularly and within macrophages, which could be reversed by excess Fe3+ 
(Lessa et al., 2012). In another study, Ga nitrate inhibited P. aeruginosa growth and biofilm 
formation, and killed planktonic and biofilm bacteria in vitro by interfering with Fe3+ uptake 
mechanisms (Chitamber, 2010). Gallium maltolate (GaM) when administered subcutaneously 
were effective in reducing S. aureus colonisation in burn wounds in the thermally injured 
mouse model (DeLeon et al., 2009). Gallium maltolate has also exhibited antibacterial activity 
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against S. aureus and methicillin-resistant S. aureus (MRSA) in different growth phases, 
including in stationary phase and biofilms, however high concentrations were required 
(Baldoni et al., 2010; Arnold et al., 2012).  
 
Gallium doped phosphate based glasses (PBGs) have recently been shown to have antibacterial 
activity (Valappil et al., 2008). Incorporating Ga3+ into a PBG system allows controlled 
delivery of Ga3+ ions which have been found to reduce biofilm growth of P. aeruginosa within 
48 hours (Valappil et al., 2008). In another study Valappil et al. (2008) reported that Ga3+ doped 
PBG demonstrated a bactericidal activity against E. coli, S. aureus and MRSA. However the 
degree of the activity varied between the bacterial species, with Gram- negative bacteria found 
to be the most susceptible to Ga3+ action.  
 
1.6.3.1 Mechanisms of action 
Iron is an essential nutrient as it acts as a cofactor of crucial enzymes involved in DNA 
synthesis, metabolism and oxidative stress response (Bonchi et al., 2014). The primary defence 
mechanism in mammalian hosts against infection is limitation of iron (Kelson et al., 2013; 
Ballouche et al., 2009). Iron is largely sequestered in either iron-transport proteins such 
transferrin and lactoferrin, stored intracellularly by ferritin, or bound in heme molecules such 
that small amounts are in the free form (Kelson et al 2013). Since the concentration of free 
circulating Fe3+ is too low for bacteria to grow, they have developed iron-acquisition and uptake 
mechanisms to sequester Fe3+ from the host environment (Kelson et al., 2013; Ballouche et al., 
2009). Bacteria can utilise siderophores, haem acquisitions systems and transferrin/lactoferrin 
receptors (Kelson et al., 2013). Siderophores are small molecules secreted by bacteria that can 
bind and internalise Fe3+. Haem uptake systems involve receptors that recognise haem, 
internalising heme via ABC-dependent transporter receptors and removing the Fe3+ by haem 
oxygenases. Some bacteria secrete haemophores, which are proteins that take up heme in the 
surroundings or extract heme from haemoproteins. Other bacteria can sequester Fe3+ directly 
from transferrin and lactoferrin via receptors that recognise these iron transport proteins 
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(Kelson et al., 2013; Ballouche et al., 2009). Despite the various uptake systems employed by 
pathogenic bacteria, the inability to distinguish Ga3+ from Fe3+ allows simple Ga3+ salts such as 
Ga3+ nitrate and GaM to reduce bacterial growth (Kelson et al., 2013; Minandri et al., 2014; 
Arnold et al., 2012).  
 
Gallium is virtually irreducible under physiological conditions, whereas Fe3+ is readily reduced 
to Fe2+. Therefore, by competing with Fe3+, Ga3+ interferes with bacterial DNA and protein 
synthesis and blocks the redox reactions that depend on iron electron acquisition (Baldoni et 
al., 2010; Bernstein. 1998). The activity of different iron-containing enzymes such as catalase, 
superoxide dismutase and ribonucleotide reductase have been shown to be reduced in bacteria 
that have been exposed to Ga3+ (Bonchi et al., 2014; Olakanmi et al., 2010; Olakanmi et al., 
2013). The ability of Ga3+ to act on several iron dependent enzymes suggests that mutation in 
a single intracellular target might not produce high level resistance to overcome Ga3+ toxicity 
(Valappil et al., 2008; Bonchi et al., 2014). 
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1.7 Aims of study 
The aims of this thesis were to: 
 Determine the antibacterial efficacy of 3 mol% gallium doped BAG at the 
concentration of 2.5 mg/ml, 5 mg/ml, 10 mg/ml, 25 mg/ml, 50 mg/ml and 100 mg/ml 
against clinically relevant microorganisms grown in planktonic cultures. The 
antibacterial efficacy of 45S5 Bioglass® will also be determined and compared to 3 
mol% gallium doped BAG. 
 Evaluate the antibacterial efficacy of the particles (direct contact) and dissolution 
products (indirect contact) of 3 mol% gallium doped BAG and 45S5 Bioglass® against 
microorganisms in planktonic phase of growth.  
 Investigate whether pH influences the antibacterial efficacy of 3 mol% gallium doped 
BAG and 45S5 Bioglass® following neutralisation, against microorganisms grown in 
planktonic cultures. 
 Assess the cytotoxic effect of 3 mol% gallium doped BAG at the concentration of 2.5 
mg, 5 mg, 10 mg, 25 mg, 50 mg and 100 mg against osteosarcoma cell line (Saos-2) 
and bone marrow derived mesenchymal cells (BMMSCs). Cytotoxicity of 45S5 
Bioglass® will also be determined and compared to 3 mol% gallium doped BAG. 
 Evaluate the effect of the particles (direct contact) and dissolution products (indirect 
contact) of both 3 mol% gallium doped BAG and 45S5 Bioglass® on the growth and 
viability of Saos-2 cells and BMMSCs.  
 Investigate the effect of 3 mol% gallium doped BAG and 45S5 Bioglass® on Saos-2 
and BMMSCs following pH neutralisation. 
 Assess and compare the influence of static incubation conditions and shaker incubation 
conditions on the antibacterial and cytotoxic activity of 3 mol% gallium doped BAG 
and 45S5 Bioglass®. 
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CHAPTER TWO 
 
 
Antibacterial Activity of Gallium doped Bioactive Glass and 45S5 
Bioglass® against Clinically Relevant Microorganisms in Planktonic 
Phase of Growth 
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2.1 INTRODUCTION  
Since the discovery of 45S5 Bioglass®, BAGs have shown great success in many clinical 
applications particularly in the dental and orthopaedic fields (Hench, 2006; Jones, 2013).  When 
BAGs were used as therapeutic materials to treat clinical conditions, such as infected frontal 
sinuses, periodontal defects, and atrophic rhinitis they were found to reduce microbial 
infections (Xie et al., 2008). Based on these results Stoor et al. (1998) explored the antibacterial 
properties of BAGs and in 1998 through experiments in vitro, they demonstrated that the 
bioactive glass S53P4 (53 mol% SiO2, 23 mol% Na2O, 20 mol% CaO, and 4 mol% P2O5) 
exhibited antibacterial efficacy on oral bacteria (Xie et al., 2008). Since then, in vitro studies 
have been conducted to determine whether BAGs exert similar antibacterial effects on skin 
pathogenic bacteria. Some authors have shown silicate-based BAGs and 45S5 Bioglass® to be 
ineffective whereas others have shown it to possess antibacterial activity. 
 
The mechanics involved in tissue integration have extensively been studied and are well known 
(Tilocca, 2010; Hoppe et al., 2011; Hench et a/., 2010). However, the mechanisms of 
antibacterial activity are still not clearly understood. Initial studies on the antibacterial efficacy 
of BAGs revealed that the activity was attributed to the high aqueous pH values caused by the 
release of cations such as, Ca2+and Na+ from BAG particles, when immersed into an aqueous 
environment (Hench et al., 1971; Mortazavi et al., 2009). It has also been reported that bacterial 
adhesion on BAG surfaces is a necessary step towards bacterial inactivation (Hu et al., 2009). 
On the contrary, Allan et al. (2000) reported that direct contact between Bioglass® and oral 
bacteria is not required to produce an antibacterial effect as the dissolution products 
significantly reduced viability in the absence of Bioglass®. Studies such as those conducted by 
Stoor et al. (1996) and Bellantone et al. (2002) demonstrated that BAGs do not possess 
bacteriostatic or bactericidal activity. The contradictory findings cast doubt on whether BAGs 
are indeed antibacterial in nature. Differences in the methodology used to measure antibacterial 
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activity, in the glass particle sizes, and in the bacterial strains may account for these 
contradictions. 
 
However, other approaches (i.e. incorporation of antibacterial ions) have been shown to 
enhance the antibacterial activity of silicate-based BAGs, whilst maintaining their bioactivity 
as well as their osteoinductive and osteoconductive properties. Moreover, BAGs are regarded 
as potential delivery systems of ions such as Ag2+ and Cu2+ with known antibacterial properties 
(Ahmed et al., 2006; Valappil et al., 2007; Pratten et al., 2004; Bellantone et al., 2002; 
Mulligan et al., 2002; Abou Neel et al 2005). Several in vitro experiments have illustrated the 
successful delivery of antibacterial ions and their inhibitory effect on microorganisms. Another 
ion which is generating great interest is Ga3+, which has been reported to target bacterial iron 
metabolism by exploiting the chemical similarities between Fe3+ ions and Ga3+ ions 
(Chitamber, 2010; Valappil et al., 2008).  
 
In vitro experiments with Ga3+ citrate and other Ga3+ based compounds provide the evidence 
that Ga3+ ions are antimicrobial in nature (Bonchi et al., 2014). The antimicrobial activity of 
Ga3+ ions following their incorporation within phosphate based glass (PBG) systems have also 
been investigated in vitro (Valappil et al., 2008). Gallium doped PBG systems have produced 
promising results in vitro, however upon degradation the phosphate component of the glass 
produces an excessively acidic pH environment and hence cytotoxicity (O’Donnell et al., 2009; 
Abou Neel et al., 2009). Furthermore, an acidic pH environment is not desirable for HCA 
formation (O’Donnell et al., 2009; Abou Neel et al., 2009) However, the slow degradation rate 
of silicate based glass systems permits HCA formation. Although, characterisation studies have 
been performed on Ga3+ containing silicate based glasses, antibacterial and cytotoxicity studies 
have yet to be conducted. 
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2.2 AIMS 
The aims of this part of the study were to: 
 Investigate and compare the antibacterial activity of 3 mol% Ga doped silicate based 
BAG and 45S5 Bioglass®.  
 Determine whether the dissolution products released from the BAGs also exhibited 
antibacterial activity.  
 Determine the influence of pH following neutralisation of 3 mol% Ga doped BAG and 
45S5 Bioglass®.  
A variety of techniques, such as direct and indirect contact, static and shaker incubation 
conditions were used. S. aureus and E. coli were chosen to represent Gram-positive and Gram-
negative bacteria, respectively.  
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2.3 METHODS AND MATERIALS  
2.3.1 Media preparation 
Nutrient agar (Oxoid Ltd, Basingstoke, UK) and nutrient broth (Oxoid Ltd, Basingstoke, UK) 
were prepared according to the manufacturer’s instructions and autoclaved at 121ºC. After 
sterilisation, 20 ml of nutrient agar (NA) was poured into petri dishes and allowed to set at 
room temperature, and 10 ml of nutrient broth (NB) was dispensed into universals, which were 
refrigerated at 4ºC.  
 
2.3.2 Microorganisms 
E. coli (NCTC 10538) and S. aureus (ATCC 6538) were stored at – 70ºC on MicroBank beads 
(Pro-Lab Diagnostics, Neston, Cheshire, UK) until required. When required, the isolates were 
revived by culture onto appropriate media and incubated according to the requirements of the 
organism. To reduce contamination and maintain viability, cultures were sub-cultured onto 
fresh plates on a weekly basis. 
 
2.3.3 Standard curves  
Overnight cell suspensions of S. aureus and E. coli were prepared in NB and incubated at 37ºC. 
At each time point (0, 1, 2, 3, 4, 5, 6, 7, 8, and 24 hours), 1 ml was removed from the cell 
suspension and the optical density (OD) was read in a spectrophotometer set to 600 nm 
following appropriate broth blanking. A range of serial dilutions from 10-1 to 10-8 were made 
and were plated onto NA plates and incubated overnight at 37ºC. The colony forming units 
(CFU)/ml were determined for each test microorganism and then plotted against OD. 
 
2.3.4 Preparation of starter cultures  
Starter cultures for each test microorganism were prepared following inoculation of NB with a 
single colony from nutrient agar NA plates. After a 24 hour incubation period at 37ºC, the 
concentration of microorganism in each starter culture was determined by OD (600 nm) and 
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compared to the standard curve described in section 2.3.3. The cultures were then diluted in 
NB as required to generate a final working concentration of 106 CFU/ml.  
 
2.3.5 Glass preparations 
45S5 Bioglass® was selected for this study as it is the most widely used BAG within the 
orthopaedic and dental fields. In addition a BAG was prepared with a similar composition but 
containing 3 mol% Ga2O3. 45S5 Bioglass® was prepared using CaCO3 (Alfa Aesar, Lancashire, 
UK) SiO2 (Alfa Aesar, Lancashire, UK), Na2CO3 (Sigma-Aldrich, Dorset, UK), H6NO4P 
(Fluka, Dorset UK). 3 mol% Ga doped BAG was prepared using CaCO3 (Alfa Aesar, 
Lancashire, UK) SiO2 (Alfa Aesar, Lancashire, UK), Na2CO3 (Sigma-Aldrich, Dorset, UK), 
H6NO4P (Fluka, Dorset UK) and Ga2O3 (Alfa Aesar, Lancashire, UK) as starting materials. 
The precursors were weighed, thoroughly mixed and placed into a 59 ml volume (90% 
platinum and 10% rhodium) crucible. The crucible was placed into a furnace at room 
temperature and then heated at 10ºC/min to1450ºC and held at this temperature for 90 minutes. 
Glass was then poured into a graphite mould that had been preheated to 370ºC. The graphite 
mould was placed back into the furnace and left overnight to slowly cool to room temperature. 
The glass rod was ground into particles (<63 microns) using a pestle and mortar and the 
particles were selected using a 63 micron sieve. The overall composition of 45S5 Bioglass® 
and 3 mol% Ga doped BAG are in table 2.1. 
 
 SiO2 
(mol%) 
Na2O 
(mol%) 
CaO 
(mol%) 
P2O5 
(mol%) 
Ga2O3 
(mol%) 
45S5 Bioglass® 46.1 24.4 26.9 2.6 0 
3 mol% Ga doped 
BAG 
43.8 23.5 25.5 2.47 3 
      Tale 2.1 Glass compositions. 
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2.3.6 pH analysis 
2.3.6.1 pH analysis at concentrations 25-100 mg/ml 
To determine the aqueous pH value of 3 mol% Ga doped BAG and 45S5 Bioglass® at 
concentrations of 25 mg, 50 mg and 100 mg, triplicate stock solutions (mg/ml) were prepared 
in 5 ml NB. Nutrient broth (5 ml) without particles served as the control. The particle 
suspensions and controls were incubated overnight at 37°C, and pH was measured using the 
Mettler Toledo pH probe (Fisher Scientific, Loughborough, UK) following 0, 6, 24, 48, 72 and 
96 hours of incubation. 
 
2.3.6.2 pH analysis at concentrations 2.5-10 mg/ml 
To determine the aqueous pH value of 3 mol% Ga doped BAG and 45S5 Bioglass® at 
concentrations of 2.5 mg, 5 mg and 10 mg, triplicate stock solutions (mg/ml) were prepared in 
5 ml NB. Nutrient broth (5 ml) without glass particles served as the control. The stock solutions 
and controls were incubated overnight at 37°C in static and shaker (with a shaking speed of 
100 rpm) incubators. The pH of the stock solutions and controls was measured using the Mettler 
Toledo pH probe, following 24, 48, 72 and 96 hours of incubation.  
 
2.3.7 Determination of the antibacterial activity of 3 mol% Ga doped BAG and 45S5 
Bioglass®  
2.3.7.1 Direct contact  
Prior to their use, the particles were UV sterilised (wavelength of 365 nm) at a distance of 18.5 
cm for 15 minutes in a UV Chromato-Vue viewing cabinet (UVP, Germany). UV sterilised 
particles of 3 mol% Ga doped BAG and 45S5 Bioglass® at 2.5 mg, 5 mg, 10 mg, 25 mg, 50 mg 
and 100 mg were added to triplicate 1 ml NB solutions. Nutrient broth without the particles 
served as the control. Samples were inoculated with the test microorganisms to give a final 
microbial concentration of 106 CFU/ml within the test carrier, then incubated overnight at 37ºC. 
Antibacterial properties of 3 mol% Ga doped BAG and 45S5 Bioglass® particles were 
evaluated under two different incubation conditions: - static and shaker (100 rpm). At each 
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time point (24, 48, 72 and 96 hours) the samples were removed, and following a serial dilute 
(10-1 to 10-8) 100 µl aliquots were spread onto NA plates, which were then incubated overnight 
at 37ºC. Following incubation, the total viable count was determined, and log growth 
reductions calculated. 
Log growth reduction = log cfu (control) – log cfu (sample)                              (Wiegand et al., 
2015). 
 
2.3.7.2 Indirect contact  
Triplicate stock solutions (mg/ml) were prepared for UV sterilised 3 mol% Ga doped BAG and 
45S5 Bioglass® particles at 2.5 mg, 5 mg, 10 mg and 100 mg in 5 ml NB. Nutrient broth (5 ml) 
without particles served as the control.  The stock solutions were incubated for 72 hours at 37ºC 
in both static and shaker (with a shaking speed of 100 rpm) incubators. Following the 72 hour 
incubation period the stock solutions were filtered using a 0.45 micron syringe filter (Sartorius 
Stedim Biotech, Goettingen, Germany). One ml was removed from the filtered stock solution 
and inoculated with the test microorganisms at a final concentration of 106 CFU/ml. The 
inoculated samples were incubated at 37ºCover a 96 hour period. The pH of the stock solution 
was measured using the Mettler Toledo pH probe. Following 24 and 96 hours of incubation 
serial dilutions ranging from 10-1 to 10-8 were performed, and 100 µl aliquots were spread onto 
NA plates, which were incubated overnight at 37ºC Following incubation, the total viable count 
was determined, and log growth reductions calculated. 
 
2.3.8 Determination of the antibacterial activity of 3 mol% Ga doped BAG and 45S5 
Bioglass® following pH neutralisation 
2.3.8.1Direct contact  
UV sterilised particles of 3 mol% Ga doped BAG and 45S5 Bioglass® at 2.5 mg, 5 mg and 10 
mg were added to triplicate 1 ml NB solutions. Nutrient broth without the 3 mol% Ga doped 
BAG and 45S5 Bioglass® particles served as the control. The samples were incubated overnight 
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at 37ºC in both static and shaker (100 rpm) incubators. After an overnight incubation period 
the samples were removed and pH readings obtained using pH probe. Once the pH was 
measured the samples were neutralised to pH 7.5. To achieve this 0.1M of hydrochloric (HCl) 
(Fisher Scientific, Loughborough, UK) acid was used with pH indicator strips (Life 
Technologies, Paisley, UK). The neutralised samples were inoculated with the test 
microorganisms at 106 CFU/ml, incubated overnight at 37ºC in both static and shaker (100 rpm) 
incubators.  At each time point the samples were removed and the pH was measured, and if 
required the pH was further neutralised to 7.5 to ensure the pH remained in the range. 
Subsequently, serial dilutions ranging from 10-1 to 10-8 were performed, followed by 100 µl 
aliquots being spread onto NA plates that were incubated overnight at 37ºC. Following 
incubation total viable count was determined, and log growth reductions calculated.  
 
2.3.8.2 Indirect contact 
Triplicate stock solutions (mg/ml) were prepared for UV sterilised 3 mol% Ga doped BAG and 
45S5 Bioglass® particles at 2.5 mg, 5 mg and 10 mg in 5 ml NB. Nutrient broth without 3 mol% 
Ga doped BAG and 45S5 Bioglass® particles served as the control. The stock solutions were 
incubated for 72 hours at 37ºC in both static and shaker (with a shaking speed of 100 rpm) 
incubators. Following the 72 hour incubation period the stock solutions were filtered using a 
0.45 micron syringe filter. One ml was removed and neutralised to achieve a pH of 7.5 using 
0.1M of HCl and inoculated with the test microorganisms at 106 CFU/ml. The remainder of the 
stock solution was used to measure the pH using a pH probe. The samples were incubated at 
37ºC and after 24 and 96 hours of incubation, the samples were removed and pH measured 
using pH strips, serial dilutions from 10-1 to 10-8 were performed and 100 µl aliquots spread 
onto NA plates, which were incubated overnight at 37ºC. Following incubation, the total viable 
count was determined, and log growth reductions calculated. 
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2.3.9 Investigation of bacterial cell adhesion on 3 mol% Ga doped BAG and 45S5 
Bioglass® particles by Scanning Electron Microscopy  
Ten mg of 3 mol% Ga doped BAG and 45S5 Bioglass® particles were added to 1 ml NB and 
inoculated with the test microorganisms at 106 CFU/ml. Glass cover slips (12 mm) (Fisher 
Scientific, Loughborough, UK) inoculated with the test microorganisms served as the control.  
Following a 24 and 96 hour incubation period at 37°C, NB was removed and serial dilutions 
ranging from 10-1 to 10-8 were performed and 100 µl aliquots spread onto NA plates, which 
were incubated overnight at 37ºC. Total viable count was determined and log growth reductions 
calculated following overnight incubation. The particles were then fixed with 2.5% 
glutaraldehyde v/v in 0.1% w/v sodium cacodylate buffer (pH 7.4) for 10 minutes, followed by 
dehydration in graded ethanol series to 100% ethanol. Following the completion of the 
dehydration step, 100% ethanol was replaced by hexamethyldisilazane (HMDS) (Sigma 
Aldrich, Dorset, UK), which was left overnight in a fume cupboard to evaporate. The samples 
were mounted onto SEM stubs and gold-coated prior to observation with a Carl Zeiss EVO 
MA10 scanning electron microscope (SEM). 
 
2.3.10 Statistical analysis 
Two-way analysis of variance (ANOVA) was carried out to determine statistical 
significances (GraphPad Prism 6.0). If a significant difference was detected a Tukey 
test and a Sidak’s test (for the neutralised experiments) were carried out to determine 
which values were significantly different. Differences were considered statistically 
significant at a level of P < 0.05.  
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2.4 RESULTS 
2.4.1 pH analysis of 3 mol% Ga doped BAG and 45S5 Bioglass® particles at 
concentrations 25 mg – 100 mg/ml 
The pH values of 45S5 Bioglass® and 3 mol% Ga doped BAG suspensions (Table 2.2) 
increased with the increase of BAG concentration over a 96 hour period. The pH value of NB 
prior to the addition of BAG particles was 8.01. Within 6 hours of soaking the pH values of 
45S5 Bioglass® particles increased from 8.01 to 10.4, 10.6 and 10.8, for 25 mg/ml, 50 mg/ml 
and 100 mg/ml, respectively. A similar increase was also observed for the particles of 3 mol% 
Ga doped BAG, the pH values were 10, at 25 mg/ml, 10.6 at 50 mg/ml and 10.7 at 100 mg/ml, 
respectively. A further increase in the pH values occurred for 45S5 Bioglass® and 3 mol% Ga 
doped BAG suspensions at 24 hours for all the concentrations tested. However, 25 mg/ml of 3 
mol% Ga doped BAG did not reach a pH of 11 until 72 hours of soaking.  
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 25 mg/ml 50 mg/ml 100 mg/ml 
Time (hours) pH pH pH 
0 8.01 8.01 8.01 
6 10.4 10.6 10.8 
24 11.0 11.1 11.2 
48 11.0 11.2 11.4 
72 11.1 11.4 11.5 
96 11.1 11.0 11.5 
 
                  25 mg/ml 50 mg/ml 100 mg/ml 
 Time (hours) pH pH  pH 
 0 8.01 8.01 8.01 
 6 10.4 10.6 10.7 
 24 10.9 11.2 11.4 
 48 10.9 11.3 11.3 
 72 11.0 11.3 11.3 
 96 11.1 11.2 11.3 
 
Table 2.2 The pH values of 45S5 Bioglass® (top) and 3 mol% Ga doped BAG (bottom) 
particles at variable concentrations, immersed in NB over a 96 hour period.  
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2.4.2 The antibacterial effect of 3 mol% Ga doped BAG and 45S5 Bioglass® at 
concentrations 25 mg – 100 mg/ml 
2.4.2.1 Direct contact 
As shown in figure 2.1, 3 mol% Ga doped BAG and 45S5 Bioglass® particles exhibited a 
significant (p = < 0.0001) antibacterial effect against E. coli. Complete growth inhibition was 
observed at 24 hours, for E. coli cultured with 50 and 100 mg/ml of 3 mol% Ga doped BAG (p 
= < 0.0001) and 45S5 Bioglass® (p = < 0.0001) particles. At 24 hours, 25 mg/ml of 3 mol% Ga 
doped BAG particles exhibited a significant antibacterial effect against E. coli, with a log 
reduction of 6.45, whereas a log reduction of 5.57 was observed for the particles of 45S5 
Bioglass®. The lower concentrations (25 mg/ml and 50 mg/ml) of both BAGs did not exhibit 
an antibacterial effect against S. aureus over a 96 hour incubation period (Figure 2.2). However 
the higher concentration tested, 100 mg/ml for both BAGs demonstrated a significant (p = 
<0.0001) growth inhibitory effect at 96 hours. 
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Figure 2.1 The antibacterial effect of 45S5 Bioglass® and 3 mol% Ga doped BAG particles against E. coli, at 25, 50 and 100 mg/ml over a 96 hour 
period. Data shown are expressed as mean (n=3) CFU/ml. 
2 4 4 8 7 2 9 6
0
3
6
9
1 2
1 5
H o u r s
L
o
g
1
0
 C
F
U
/m
l
0  m g  4 5 S 5  B G
2 5  m g  4 5 S 5  B G
5 0  m g  4 5 S 5  B G
1 0 0  m g  4 5 S 5  B G
0  m g  3 %  G a  B A G
2 5  m g  3 %  G a  B A G
5 0  m g  3 %  G a  B A G
1 0 0  m g  3 %  G a  B A G
**** ****
**** ****
**** ****
****
****
****
****
****
****
****
****
****
****
****
****
****
****
****
****
****
****
~ 69 ~ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 The antibacterial effect of 45S5 Bioglass® and 3 mol% Ga doped BAG particles against S. aureus, at 25, 50 and 100 mg/ml over a 96 hour 
period. Data shown are expressed as mean (n=3) CFU/ml.
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2.4.2.2 Indirect contact 
Figures 2.3 shows the antibacterial effect of the dissolution products of 3 mol% Ga doped BAG 
and 45S5 Bioglass® when tested against E. coli, at 100 mg/ml. At 24 hours, the dissolution 
products of 3 mol% Ga doped BAG and 45S5 Bioglass® completely inhibited (p = < 0.0001) 
the growth of E. coli, with a log reduction of 8.38. Figure 2.4 shows the antibacterial effect of 
the dissolution products for both BAGs when tested against S. aureus. 45S5 Bioglass® exerted 
a greater antibacterial action (p = < 0.0001) as S. aureus growth was completely inhibited 
within 24 hours, whilst the dissolution products of 3 mol% Ga doped BAG (p = < 0.0001) 
reduced S. aureus growth with a log reduction of 6.47. 
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Figure 2.3 The antibacterial effect of 45S5 Bioglass® and 3 mol% Ga doped BAG dissolution products against E. coli at 100 mg/ml over a 96 hour 
period. NB was conditioned with 100 mg/ml of 45S5 Bioglass® and 3 mol% Ga doped BAG particles and kept in a static incubator. Data shown are 
expressed as mean (n=3) CFU/ml. 
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Figure 2.4 The antibacterial effect of 45S5 Bioglass® and 3 mol% Ga doped BAG dissolution products against S. aureus, over a 96 hour period. NB 
was conditioned with 100 mg/ml of 45S5 Bioglass® and 3 mol% Ga doped BAG particles and kept in a static incubator. Data shown are expressed as 
mean (n=3) CFU/ml
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2.4.3 pH analysis of 3 mol% Ga doped BAG and 45S5 Bioglass® particles at 
concentrations 2.5 -10 mg 
pH values of NB containing 45S5 Bioglass® and 3 mol% Ga doped BAG particles increased 
with the increase of particles under both static (Figure 2.5) and shaker (Figure 2.6) incubation 
conditions. Nutrient broth containing 45S5 Bioglass® showed a statistically significant (p = < 
0.0001) pH rise, which rose to 8.8, 9.2 and 9.5 for 2.5, 5 and 10 mg/ml concentrations, 
respectively, after 24 hours under static incubation conditions. Similarly, pH values for NB 
containing 3 mol% Ga doped BAG particles also significantly (p = < 0.0001) increased to 8.8, 
9.1 and 9.4 for 2.5, 5 and 10 mg/ml concentrations, respectively, in comparison to NB without 
particles. Enquire  
 
Under shaker incubation conditions the pH values of the variable concentrations tested 
increased. The pH values significantly (p = < 0.0001) increased to 8.7, 9.2, and 9.6 for 45S5 
Bioglass® particle concentrations 2.5, 5 and 10 mg/ml, respectively, after 24 hours. Likewise, 
3 mol% Ga doped BAG particles also raised the pH of the NB to 8.8, 9.2 and 9.5 for 2.5, 5 and 
10 mg/ml concentrations. A further increase in pH was not observed for either 45S5 Bioglass® 
and 3 mol% Ga doped BAG particles after the initial increase reported at 24 hours for static 
and shaker incubation conditions.  
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Figure 2.5 pH analysis of variable concentrations of (A) 45S5 Bioglass® and (B) 3 mol% Ga 
doped BAG particles immersed in NB over a 96 hour period, under static incubation conditions. 
Data shown are expressed as means ± SD (n=2). 
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Figure 2.6 pH analysis of variable concentrations of (A) 45S5 Bioglass® and (B) 3 mol% Ga 
doped BAG particles immersed in NB over a 96 hour period, under shaker incubation 
conditions. Data shown are expressed as means ± SD (n=2).  
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2.4.4 Determination of the antibacterial activity of 3 mol% Ga doped BAG and 45S5 
Bioglass® at concentrations 2.5-10 mg/ml 
2.4.4.1 Direct contact 
2.4.4.1.1 Static incubation conditions  
As shown in figure 2.7, 3 mol% Ga doped BAG and 45S5 Bioglass® particles exhibited a 
statistically significant antibacterial effect (p = < 0.0001) against E. coli at the concentration of 
10 mg/ml. A log reduction of 5.40 and 4.21 was observed at 24 hours, for E. coli cultured with 
3 mol% Ga doped BAG (p =< 0.0001) and 45S5 Bioglass® (p =< 0.0001) particles, 
respectively. Despite a reduction in the number of viable cells at the earlier time points, at 96 
hours a rise was observed for E. coli cultured with 3 mol% Ga doped BAG particles. The 
particles of 45S5 Bioglass® however continued to significantly reduce E. coli growth with a 
log reduction of 7.73 (p = < 0.0001), whereas 3 mol% Ga doped BAG particles caused a log 
reduction of 6.93 (p = < 0.0001). No statistical significant difference was observed between 
the two glass types. 
 
Figure 2.8 shows the antibacterial effect of 3 mol% Ga doped BAG and 45S5 Bioglass® 
particles against S. aureus. 3 mol% Ga doped BAG and 45S5 Bioglass® particles did not 
display a similar antibacterial action against S. aureus as E. coli. A statistical difference was 
observed at 72 (p = < 0.01) and 96 (p = < 0.05) hours between control (0 mg/ml) cultures and 
S. aureus cultures containing 10 mg/ml of 45S5 Bioglass®. 
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Figure 2.7 The antibacterial effect of 45S5 Bioglass® and 3 mol% Ga doped BAG particles at varying concentrations against E. coli under static 
incubation conditions, over a 96 hour period. Data shown are expressed as mean (n=3) CFU/ml. 
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Figure 2.8 The antibacterial effect of 45S5 Bioglass® and 3 mol% Ga doped BAG particles at varying concentrations against S. aureus under static 
incubation conditions over a 96 hour period. Data shown are expressed as mean (n=3) CFU/ml.
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2.4.4.1.2 Shaker incubation conditions  
Under shaker incubation conditions at 10 mg/ml 3 mol% Ga doped BAG and 45S5 Bioglass® 
particles totally inhibited E. coli growth within 48 hours (p = < 0.0001), with a log reduction 
of 9.26 and 9.45, respectively (Figure 2.9). 45S5 Bioglass® revealed a significant antibacterial 
activity (p = < 0.0001) as a 1.58 log reduction was seen for 5 mg/ml at 48 hours. Lower 
concentrations of 3 mol % Ga doped BAG also exhibited a significant antibacterial effect at 
the earlier time points (p = < 0.0001), similarly to 45S5 Bioglass®. 
3 mol% Ga doped BAG and 45S5 Bioglass® particles did not inhibit S. aureus under shaker 
incubation conditions (Figure 2.10). A statistical significant (p = < 0.01) reduction was 
observed for S. aureus cultures containing 10 mg/ml of 45S5 Bioglass® particles at 24 hours, 
but following 24 hours no further reduction was noted.
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Figure 2.9 The antibacterial effect of 45S5 Bioglass® and 3 mol% Ga doped BAG particles at varying concentrations against E. coli under shaker 
incubation conditions over a 96 hour period. Data shown are expressed as mean (n=3) CFU/ml. 
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Figure 2.10 The antibacterial effect of 45S5 Bioglass® and 3 mol% Ga doped BAG particles at varying concentrations against S. aureus under shaker 
incubation conditions over a 96 hour period.  Data shown are expressed as mean (n=3) CFU/m
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2.4.4.2 Indirect contact  
2.4.4.2.1 Static incubation conditions 
Figure 2.11 shows the antibacterial effect of the dissolution products of 3 mol% Ga doped BAG 
and 45S5 Bioglass® when tested against E. coli. At 24 hours the dissolution products of 45S5 
Bioglass® displayed a statistical significant antibacterial effect against E. coli at 5 mg/ml (p = 
0.009) and 10 mg/ml (p = 0.001), with log reductions of 1.08 and 1.33 respectively. In contrast, 
no antibacterial effect was observed for the dissolution products of 3 mol% Ga doped BAG 
particles. However, at 96 hours the dissolution products of 3 mol% Ga doped BAG at 10 mg/ml 
exhibited a significant (p = < 0.05) antibacterial effect with a log reduction of 1.17, whilst 45S5 
Bioglass® did not demonstrate a statistical significant reduction in the antibacterial effect with 
a log reduction of 1.   
 
The antibacterial activity of the dissolution products of 3 mol% Ga doped BAG and 45S5 
Bioglass® when tested against S. aureus can be seen in figure 2.12. It was found that at 24 hours 
the dissolution products of 45S5 Bioglass® demonstrated a significant antibacterial effect at 5 
mg/ml and 10 mg/ml (p = < 0.01), whilst those of 3 mol% Ga doped BAG possessed no 
antibacterial activity. At 96 hours the dissolution products of 45S5 Bioglass® were unable to 
maintain the antibacterial effect achieved at 24 hours.  
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Figure 2.11 The antibacterial effect of the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped BAG against E. coli over a 96 hour period. 
NB was conditioned with variable concentrations of 45S5 Bioglass® and 3 mol% Ga doped BAG particles and kept in a static incubator. Data shown 
are expressed as mean (n=3) CFU/ml. 
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Figure 2.12 The antibacterial effect of the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped BAG against S.aureus over a 96 hour period. 
NB was conditioned with variable concentrations of 45S5 Bioglass® and 3 mol% Ga doped BAG particles and kept in a static incubator.  Data shown 
are expressed as mean (n=3) CFU/ml.
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2.4.4.2.2 Shaker incubation conditions 
The level of activity varied between 3 mol% Ga doped BAG and 45S5 Bioglass®, with 3 mol% 
Ga doped BAG dissolution products possessing a greater antibacterial action when tested 
against E. coli (Figure 2.13). This was particularly evident at 96 hours with 10 mg/ml, where a 
5.24 log reduction was observed for 3 mol% Ga doped BAG (p = 0.0001) dissolution products 
and a 3.99 for 45S5 Bioglass® (p = 0.001). The lower concentrations investigated also 
demonstrated antibacterial effects. At 96 hours the dissolution products of 3 mol% Ga doped 
BAG (p = < 0.01) and 45S5 Bioglass® exhibited a significant antibacterial action at 5 mg/ml, 
with log reductions of 1.48 and 1.45, respectively. A statistical significant antibacterial effect 
was observed for 3 mol% Ga doped BAG dissolution products at 2.5 mg/ml with a log 
reduction of 0.78 at 96 hours (p = 0.02), whilst 45S5 Bioglass® possessed no antibacterial 
activity. It was also found that the antibacterial activity was time dependent, as the earlier time 
point (24 hours) represented a strong antibacterial effect whilst at 96 hours a slight antibacterial 
effect was observed.  
 
As shown in figure 2.14 the dissolution products of 3 mol% Ga doped BAG had no antibacterial 
effect against S. aureus. However, the dissolution products of 45S5 Bioglass® produced a 
significant (p = < 0.0001) antibacterial effect against S. aureus at 5 mg/ml and 10 mg/ml (Figure 
2.14). Unlike, the effect observed against E. coli the antibacterial activity of dissolution 
products when tested against S. aureus was not time dependent. At 10 mg/ml a 1.80 log 
reduction was observed at 24 hours, whilst at 96 hours the log reduction was 1.14. A similar 
pattern was also observed for 2.5 mg/ml and 5 mg/ml. 
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Figure 2.13 The antibacterial effect of the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped BAG against E. coli over a 96 hour period. 
NB was conditioned with variable concentrations of 45S5 Bioglass® and 3 mol% Ga doped BAG particles and kept in a shaker incubator. Data shown 
are expressed mean (n=3) CFU/ml. 
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Figure 2.14 The antibacterial effect of the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped BAG against S. aureus over a 96 hour period. 
NB was conditioned with variable concentrations of 45S5 Bioglass® and 3 mol% Ga doped BAG particles and kept in a shaker incubator. Data expressed 
as mean (n=3) CFU/ml.
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2.4.5 Determination of the antibacterial activity of 3 mol% Ga doped BAG and 45S5 
Bioglass® at concentrations 2.5-10 mg/ml following pH neutralisation 
2.4.5.1 Direct contact 
2.4.5.1.1 Static incubator conditions 
At 10 mg/ml both 3 mol% Ga doped BAG and 45S5 Bioglass® particles showed no 
antibacterial activity against E. coli (Figure 2.15) and S .aureus (Figure 2.16) under static 
incubation conditions following pH neutralisation.  
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Figure 2.15 The antibacterial effect of pH neutralised 45S5 Bioglass® and 3 mol% Ga doped BAG particles at 10 mg/ml against E. coli over a 96 hour 
period, under static incubation conditions. Data shown are expressed as mean (n=3) CFU/ml. 
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Figure 2.16 The antibacterial effect of pH neutralised 45S5 Bioglass® and 3 mol% Ga doped BAG particles at 10 mg/ml against S. aureus over a 96 
hour period, under static incubation conditions. Data shown are expressed as mean (n=3) CFU/ml.
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2.4.5.1.2 Shaker incubation conditions  
Following neutralisation of the pH the particles of 3 mol% Ga doped BAG and 45S5 Bioglass® at the 
concentration of 10 mg/ml were unable to produce an antibacterial effect under shaker incubation 
conditions, against E. coli (Figure 2.17) and S. aureus (Figure 2.18).
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Figure 2.17 The antibacterial effect of pH neutralised 45S5 Bioglass® and 3 mol% Ga doped BAG particles at 10 mg/ml against E. coli over a 96 hour 
period, under shaker incubation conditions. Data shown are expressed as mean (n=3) CFU/ml. 
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Figure 2.18 The antibacterial effect of pH neutralised 45S5 Bioglass® and 3 mol% Ga doped BAG particles at 10 mg/ml against S. aureus over a 96 
hour period, under static incubation conditions.  Data shown are expresses as mean (n=3) CFU/ml.
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2.4.5.2 Indirect contact  
2.4.5.2.1 Static incubation conditions 
The dissolution products of 3 mol% Ga doped BAG and 45S5 Bioglass® were unable to inhibit 
the growth of both E. coli (Figure 2.19) and S. aureus (Figure 2.20) following pH neutralisation.  
 
 
 
 
Figure 2.19 The antibacterial effect of pH neutralised 45S5 Bioglass® and 3 mol% Ga doped 
BAG dissolution products at 10 mg/ml against E. coli, over a 96 hour period, under static 
incubation conditions. Data shown expressed as mean (n=3) CFU/ml. 
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Figure 2.20 The antibacterial effect of pH neutralised 45S5 Bioglass® and 3 mol% Ga doped 
BAG particles at 10 mg/ml against S. aureus over a 96 hour period, under static incubation 
conditions. Data shown are expressed as mean (n=3) CFU/ml.
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2.4.5.2.2 Shaker incubation conditions 
Under shaker incubation conditions the neutralisation of the pH rendered the dissolution 
products of 3 mol% Ga doped BAG and 45S5 Bioglass® ineffective at inhibiting E. coli (Figure 
2.21) and S. aureus (Figure 2.22) growth.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.21 The antibacterial effect of pH neutralised 45S5 Bioglass® and 3 mol% Ga doped 
BAG dissolution products at 10 mg/ml against E. coli over a 96 hour period, under shaker 
incubation conditions. Data shown are expressed as mean (n=3) CFU/ml. 
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Figure 2.22 The antibacterial effect of pH neutralised 45S5 Bioglass® and 3 mol% Ga doped 
BAG dissolution products at 10 mg/ml against S. aureus over a 96 hour period, under shaker 
incubation conditions. Data shown are expressed as mean (n=3) CFU/ml. 
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2.4.6 Investigation of bacterial cell adhesion on 3 mol% Ga doped BAG and 45S5 
Bioglass® particles by Scanning Electron Microscopy  
The SEM images demonstrate bacterial adhesion on the surface of 3 mol% Ga doped BAG and 
45S5 Bioglass® particles. However, the degree of adhesion varied between E. coli (Figure 2.23) 
and S. aureus (Figure 2.25). Whilst both S. aureus and E. coli were able to adhere to 3 mol% 
Ga doped BAG and 45S5 Bioglass® a higher level of adherence was observed with S. aureus. 
Furthermore, it was observed that relatively the same number of bacterial cells were attached 
onto the surface of 3 mol% Ga doped BAG and 45S5 Bioglass® particles at both 24 and 96 
hours for both microorganisms tested.  
 
The particles of 45S5 Bioglass® and 3 mol% Ga doped BAG exhibited a statistical significant 
antibacterial effect when tested against E.coli (Figure 3.24). 45S5 Bioglass® produced a log 
reduction of 2.1 (p = < 0.002), whilst a 1.6 log (p = < 0.0007) reduction was observed for 3 
mol% Ga doped BAG at 96 hours. However, the particles of both glasses were unable to inhibit 
S. aureus growth (Figure 2.26) over a 96 hour incubation period.  
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Figure 2.23 SEM images of (A) E. coli cultured onto a cover slip following a 24 hour 
incubation period, at 5.00 kV and WD = 7.5 mm, (B) E. coli cultured onto a cover slip following 
a 96 hour incubation period, at 5.00 kV and WD = 7.5 mm, (C) E. coli cultured onto 45S5 
Bioglass® particles at 24 hours, at 5.00 kV and WD = 8.0 mm, (D) E. coli cultured onto 45S5 
Bioglass® particles at 96 hours, at 5.00 kV and WD = 8.5 mm, (E) E. coli cultured onto 3 mol% 
Ga doped BAG particles at 24 hours, at 5.00 kV and WD = 7.5 mm, and (F) E. coli cultured 
onto 3 mol% Ga doped BAG particles at 96 hours, at 5.00 kV and WD = 7.5 mm. Bar represents 
2 µm. 
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Figure 2.24 Mean CFU/ml (n=3) of E. coli cultured onto glass cover slip (0 mg/ml), 45S5 
Bioglass® and 3 mol% Ga doped BAG particles (10 mg/ml) following a 24 and 96 hour 
incubation period, for SEM analysis.   
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Figure 2.25 SEM images of S. aureus cultured onto 45S5 Bioglass® and 3 mol% Ga doped 
BAG particles following 24 and 96 hours incubation, at 15.00 kV and WD = 6.5 mm. (A) S. 
aureus cultured onto a cover slip following a 24 hour incubation period, (B) S. aureus cultured 
onto a cover slip following a 96 hour incubation period, (C) S. aureus cultured onto 45S5 
Bioglass® particles at 24 hours, (D) S. aureus cultured onto 45S5 Bioglass® particles at 96 
hours, (E) S. aureus cultured onto 3 mol% Ga doped BAG particles following 24 hours, at 
15.00 kV and WD = 6.0 mm, and (F) S. aureus cultured onto 3 mol% Ga doped BAG particles 
following 96 hours, at 15.00 kV and WD = 6.0 mm. Bar represents 2 µm. 
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Figure 2.26 Mean CFU (n=3) of S. aureus cultured onto glass cover slip (0 mg/ml), 45S5 
Bioglass® and 3 mol% Ga doped BAG particles(10 mg/ml) following a 24 and 96 hour 
incubation period, for SEM analysis. 
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2.5 DISCUSSION 
A growing body of data demonstrates that Ga3+ compounds are antibacterial as are Ga3+ doped 
PBG systems. However, the antibacterial efficacy of Ga3+ ions when incorporated within a 
silicate-based glass system has not been investigated. In this study the antibacterial action of 
silicate-based glass system doped with 3 mol% Ga3+ was investigated using E. coli and S. 
aureus. Furthermore, the antibacterial efficacy of 45S5 Bioglass® was also investigated and 
compared.  
 
The results for this study demonstrated that 3 mol% Ga doped BAG produced a similar 
antibacterial effect as 45S5 Bioglass® particles. The antibacterial effect was concentration 
dependent, as reduced survival was observed at the highest concentrations tested. 45S5 
Bioglass® and 3 mol% Ga doped BAG at 50 mg/ml and 100 mg/ml inhibited E. coli growth but 
could only inhibit S. aureus at 100 mg/ml. The results of the current study are consistent with 
previous findings, which have demonstrated concentration-dependent kill. Munukka et al. 
(2008) investigated the antibacterial efficacy of eight BAGs against 29 clinically important 
bacterial species. They demonstrated that all BAGs had a growth-inhibitory effect at the highest 
concentration tested, 100 mg/ml. In addition, Hu et al. (2009) reported that bacterial kill over 
98% could be achieved for E. coli, S. aureus and S. epidermidis at the 45S5 Bioglass® 
concentrations of 50 mg/ml and 100 mg/ml. When BAGs are immersed into aqueous solutions 
Ca2+, Na+, PO43- and Si4+ ions are released and as a result elevate the pH and osmotic pressure 
of the environment. Jones et al. (2001) reported that the dissolution of Ca2+, Na+, PO43- and Si4+ 
ions into solution increased as glass particle concentration in solution increased. This may 
explain the growth inhibition at the highest concentrations, as the pH values measured ranged 
from 10 – 11. However, the antibacterial effect was found to vary between the bacterial species, 
as both BAGs at 100 mg/ml inhibited E.coli growth within 24 hours of culture, whereas reduced 
survival for S. aureus occurred at 96 hours. 
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The initial glass concentrations (25 mg/ml, 50 mg/ml and 100 mg/ml) in this study were chosen 
based on previous studies (Mannukka et al., 2008; Hu et al., 2009; Allan et al., 2001; Mortazavi 
et al., 2010; Leppäranta et al., 2008; Zhang et al., 2010) however, these concentrations were 
found to exhibit cytotoxic effects against osteoblast-like Saos-2 cells and bone marrow derived 
MSCs (see chapter 3), and therefore lower concentrations (2.5 mg/ml, 5 mg/ml and 10 mg/ml) 
were chosen. The difference between E. coli and S. aureus was also observed at the lower 
concentrations tested. It was evident from the direct contact experiments that both 3 mol% Ga 
doped BAG and 45S5 Bioglass® did not exhibit broad-spectrum antibacterial properties, as 
reduced survival could only be demonstrated for E. coli but not for S. aureus.  
 
In agreement with the results presented here, Valappil et al. (2008) reported that the zones of 
inhibitions were larger for E. coli and P. aeruginosa than S. aureus, when investigating the 
antibacterial action of Ga3+ doped PBGs. The difference has also been observed with Ga3+ 
compounds, such as Ga3+ (III) protoporphyrin IX (PPIX) complex (Ga (III)-PPIX), which has 
demonstrated potent antibacterial activity against both Gram-negative and Gram–positive 
bacteria. However, the antibacterial effect of Ga3+ (III)-PPIX was markedly greater for E. coli 
with a minimum inhibitory concentration (MIC) of <0.5 µg/ml, whilst the effective 
concentration doubled for S. aureus with a MIC of 1.0-2.5 µg/ml (Minandri et al., 2014). 
Similar findings were also observed for 45S5 Bioglass® in a study conducted by Hu et al. 
(2009), in which a significant difference was seen between Gram-negative bacterium (E. coli) 
and Gram-positive bacteria (S. aureus and S. epidermidis) at the lowest concentration tested, 
10 mg/ml. 
 
The difference observed between S. aureus and E. coli could be attributed to their cell 
structures. The cell wall of Gram-positive bacteria is primarily composed of a thick 
peptidoglycan layer however it also contains large amounts of teichoic and lipotechoic acids. 
Doyle et al. (1980) and Hughes et al. (1972) demonstrated that the teichoic acids (which 
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provide highly charged anionic clusters) contribute to the binding of metal ions such as Na+ 
and Ca2+ ions to the cell wall. Beveridge and Murray, (1976) suggested that the carboxyl groups 
of peptidoglycan were also responsible for the interactions between cell walls and cations. It 
has been suggested by Stoor et al. (1996) that BAGs are subject to bacterial adhesion due to 
the presence of Ca2+ ions in the Si-rich layer. This could explain why no reduced survival was 
observed for S. aureus. The metal binding sites present in the cell wall probably mediated the 
binding of S. aureus onto the surface of 3 mol% Ga doped BAG and 45S5 Bioglass® particles. 
Moreover both BAGs are known to produce a Si-rich layer in an aqueous environment and 
release Ca2+ and Na+ ions. The SEM images of this study also support these findings, as greater 
numbers of S. aureus were seen on the surface of both 3 mol% Ga doped BAG and 45S5 
Bioglass® particles. Gorriti et al. (2009) reported S. aureus adhesion on 45S5 Bioglass® 
scaffold, and furthermore it was unable to significantly affect the viability of S. aureus. 
However, this does not apply to E. coli, which is a Gram-negative bacterium. The cell wall of 
E. coli is composed of a thin peptidoglycan layer with no teichoic acids enclosed within its 
outer membrane. Hu et al. (2009) reported that needle like BAG debris was adsorbed onto the 
surface of E. coli, which led to the destruction of the cell wall. In addition, the higher local pH 
value measured on the surface of the Bioglass® particles was believed to potentiate the 
antibacterial effect of Bioglass® particles by destroying the bacterial structure. The SEM 
images show very few numbers of E. coli on the surface of both 3 mol% Ga doped BAG and 
45S5 Bioglass® particles.  
 
Indirect contact experiments were conducted to elucidate whether the dissolution products 
would be sufficient to inhibit cell growth, and also if particle presence is necessary for bacterial 
inactivation. The results of the indirect contact experiments show that 3 mol% Ga doped BAG 
and 45S5 Bioglass® particles were only effective at the highest concentrations tested at reducing 
bacterial growth, particularly E. coli growth. There was a noticeable difference between the 
two incubation conditions, as E. coli growth was greatly reduced under shaker incubation 
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conditions. It was also evident that the dissolution products of 3 mol% Ga doped BAG 
produced a greater antibacterial action than those of 45S5 Bioglass®, under shaker incubation 
conditions. Similarly, at 25 mg/ml the particles of 3 mol% Ga doped BAG demonstrated a 
significant inhibitory effect against E. coli. 
 
It can be inferred that the inclusion of Ga3+ ions within the BAG system enhances its 
antibacterial action. It has been reported that Ga3+ ions target bacterial iron metabolism by 
exploiting the chemical similarities between Fe3+ ions and Ga3+ ions (Chitamber, 2010; 
Valappil et al., 2008). The ability of Ga3+ ions to easily substitute for Fe3+ ions, allows it to 
interfere with many iron-requiring enzymes, including ribonucleotide reductase, which 
catalyses the first step in DNA synthesis, and superoxide dismutase and catalase which protect 
against oxidative stress (Valappil et al., 2008). Despite the presence of Ga3+ ions the 
antibacterial effect could also have been attributed to the Ca2+ and Na+ ions, which increase 
aqueous pH. As small concentrations of Ga3+ ions are released from Ga3+ doped BAGs. 
Franchini et al. (2012) reported that after 24 hours the concentration of Ga3+ ions was 4.3 ppm 
whereas 101 and 3490 ppm was observed for Ca2+ and Na+ ions respectively, which were 
released from 3.5 mol% Ga doped silicate-based  BAG.  However, this Ga3+ ion concentration 
should be sufficient to exert an antibacterial activity as concentrations as low as 0.007-1.4 ppm 
were reported to disrupt P. aeruginosa iron metabolism (Kaneko et al., 2007).  
 
The dissolution products did not only reduce the growth of E. coli as growth reduction was also 
observed for S. aureus but the degree of reduction varied. The outer membrane of E. coli is 
embedded with porins, which are nonspecific pores or channels that allow the passage of small 
hydrophilic molecules across the outer membrane (Nikaido, 2013). Calcium and Na+ are small 
hydrophilic ions and could therefore utilise the porin pathway to enter E. coli and once inside 
elevate the intracellular pH, resulting in cell death. Furthermore, elevated pH levels of the 
medium attributed to the alkali ions, can alter the pH gradient present in the cytoplasmic 
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membrane of bacteria, which is important for the movement of nutrients into the cell. 
Therefore, by influencing the transfer and permeability of the cytoplasmic membrane, the high 
pH can induce inhibition and toxic effects on the bacteria (Xie et al., 2008). S. aureus lacks an 
outer membrane and its cell wall binds Ca2+ and Na+ ions, therefore the dissolution products 
did not display a similar level of antibacterial efficacy. Moreover, Cutinelli and Galdiero. 
(1967) demonstrated that an increased pH (of 9) increased the amount of ions bound by S. 
aureus cell wall. In this study the concentration of 10 mg/ml caused alkalisation of NB with 
values as high as 9. An increased pH deprotonates functional groups within the cell wall, 
resulting in an increasing number of sites available for metal adsorption (Fowle and Fein, 
1999). However, 100 mg/ml demonstrated a significant antibacterial efficacy against S. aureus, 
which could be attributed to the high levels of dissolution products present in the media. It can 
therefore be assumed that S. aureus is able to survive in a mildly alkaline environment produced 
by the lower concentrations of BAGs, but cannot tolerate an extreme alkaline environment. 
These results indicate that the presence of bioactive glass particles play an important role in the 
antibacterial effect against E. coli but not S. aureus.  
 
Only one in vivo study has been conducted to evaluate the antibacterial activity of BAGs and 
it showed that particulate Bioglass® does not exhibit antibacterial activity in vivo. Xie et al. 
(2008) suggested that the inactivity of particulate Bioglass® in vivo was due to the ‘big buffer 
system’ in body fluid, which could swiftly exchange dissolution products with nearby blood 
and other body fluid, so the ionic concentration and pH in body fluid at the site of implantation 
cannot increase to sufficient high levels required to inhibit bacterial growth. In this current 
study the pH was neutralised to investigate the effect of pH adjustment on the antibacterial 
activity of 3 mol% Ga doped BAG and 45S5 Bioglass®. It was found that following pH 
neutralisation, 3 mol% Ga doped BAG and 45S5 Bioglass® were ineffective at inhibiting E. 
coli and S. aureus growth. The results for the neutralised experiments are consistent with the 
in vitro study conducted by Allan et al. (2001) in which no difference was reported between 
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the control group and pH adjusted Bioglass® supernates. It has been suggested that a reduction 
in the pH may alter the solubilities of particular ions present in the BAG which at a higher pH 
could be responsible for the antibacterial effect (Allan et al., 2001). The results of the 
neutralisation experiments provide evidence that pH alone may be responsible for the 
antibacterial activity.  
 
Incubation conditions influenced the antibacterial effect of the particles. The particles 
significantly inhibited E. coli growth under shaking incubation conditions. This could be 
contributed to the fact that particles under shaking conditions are suspended in solution. 
Therefore, are far more likely to come into contact with the solution resulting in increased 
dissolution. Under static incubation conditions particles on the top layer are more likely to be 
exposed to the solution. However, even under shaking conditions 45S5 Bioglass® particles were 
unable to exhibit a strong antibacterial effect against S. aureus. This could be a result of S. 
aureus adhering onto the surface of the particles, and reducing the dissolution rate. The 
dissolution products are therefore unable to penetrate through the layer of cells in close contact 
to the particles that may have protected the cells in suspension. When investigating the 
attachment of E. coli and S. aureus on the surface of glass particles the total viable CFU count 
was also determined. The results for S. aureus were similar to those obtained for the direct 
contact experiments, however significant growth reduction was not observed for E. coli. This 
could be because the particles formed a dome when immersed into NB, shielding the particles 
under the dome from the solution and hence reducing dissolution. Therefore, the release of 
dissolution products is required to produce an antibacterial effect against E. coli.  
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2.6 CONCLUSION 
3 mol% Ga doped BAG possesses similar antibacterial properties to 45S5 Bioglass®, and 
neither exhibit broad-spectrum antibacterial activity, as total growth inhibition was only 
observed for E. coli at the highest concentrations. This study illustrates that possibly two 
aspects are involved in the antibacterial effect of 3 mol% Ga doped BAG and 45S5 Bioglass® 
particles against E. coli, the high aqueous pH and contact between particles and bacterial cells, 
however even in the presence of particles the BAGs are ineffective at inhibiting S. aureus 
growth. The neutralisation experiments demonstrate that the antibacterial action is primarily 
driven by pH. The fact that the bacterial cells could withstand the antibacterial effect of the 
particles following pH neutralisation raises the question whether the two BAGs investigated 
would be effective antibacterial agents in vivo. These results highlight the importance of pH 
neutralisation in vitro, and also that results obtained will largely be influenced by the method 
and concentrations selected, glass composition and bacterial strains.  
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CHAPTER THREE 
 
 
 
The Effects of Gallium doped Bioactive Glass and 45S5 Bioglass® on 
the Growth and Viability of Human Mesenchymal Stem Cells and 
Osteoblast-like Cells In Vitro 
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3.1 INTRODUCTION 
Bioactive glasses have the ability to form a strong bond with living tissue due to the formation 
of a HCA layer on their surface and have been used clinically to repair craniofacial, 
maxillofacial and periodontal tissues (Hench et al., 2006; Hench. 2010). Existing research has 
established that BAGs allow adhesion, proliferation and differentiation of healthy osteoblasts 
on their surfaces in vitro (Xynos et al., 2000; Labbaf et al., 2011; Mayr-Wohlfart et al., 2000; 
Silver et al., 2001; Valerio et al., 2003; El-Ahmed et al., 1995; Christodoulou et al., 2005). 
Similarly, in vivo studies have reported gradual degradation of implanted BAGs with 
subsequent bone formation at the implant surface (Hamadouche et al., 2001; Livingston et al., 
2002; Vogel et al., 2001; Heikkilae et al, 1995). These findings suggest that BAGs have 
potential in bone repair, e.g. to enhance bone formation following fracture or following 
resections of bone tumours.  
 
Initial studies investigating the antineoplastic activity of Ga3+ revealed that patients with 
advanced malignant lymphoma receiving Ga3+ nitrate frequently became hypocalcaemic (the 
presence of low serum Ca2+ levels in the blood). This observation led to further investigations 
which evaluated the role Ga3+ played in bone metabolism. It was found that Ga3+ would 
suppress bone resorption by inhibiting osteoclast action without evidence of cytotoxic effects 
on osteoblasts (bone forming cells) (Bockman et al., 1990). This antiresorptive activity has led 
to its clinical use in the treatment of hypercalcaemia (presence of high serum Ca2+ levels in the 
blood) of malignancy and other metabolic bone disorders characterised by increased bone 
resorption by osteoclasts (Chitamber, 2010; Warrell, 1997; Bernstein, 2013).  In addition to 
acting on osteoclasts to inhibit bone resorption, Ga3+ has also been reported to stimulate bone 
formation by acting directly on osteoblasts (Bernstein et al., 1998). Several authors have 
demonstrated that Ga3+ increases the expression of type-I collagen and OCN in osteoblasts, 
proteins which are involved in differentiation and bone mineralisation (Jenis. 1993; Bockman. 
1993). Furthermore, Ga3+ doped silicate-based glass systems maintain the ability of HCA 
formation in vitro when immersed into physiological fluids (Franchini et al., 2012; Lusvardi et 
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al, 2013). Gallium could therefore be used to dope silicate-based glass systems, in order to 
manufacture a material that would combine the bone bonding properties of silicate-based glass 
systems with the antiresorptive and anabolic properties of Ga3+, and may act as an effective 
material for bone regeneration.    
 
Previous in vitro studies examining osteogenic properties of BAGs have utilised primary 
human osteoblasts as well as osteoblast-like cell lines, such as Saos-2 cells as the prototypes 
for osteoblastic cells. The osteosarcoma tumour cell line, Saos-2 which has been isolated from 
an 11 year old Caucasian female in 1975 has been used to investigate the cytocompatibility of 
various BAGs (Mayr-Wohlfart et al., 2001; Alcaide et al., 2010; Gentleman et al., 2010; Gao 
et al., 2001). Despite being a tumour cell line, Saos-2 cells exhibit many osteoblastic traits such 
as high levels of ALP activity and the ability to synthesise OCN and collagen type I which are 
characteristic of bone forming cells (Czekanska et al., 2012).  Furthermore, these cells are 
highly proliferative and can be cultured to perform a large number of experiments over a 
relatively short period of time. Several in vitro studies have reported osteogenic effects of 
various BAG compositions on animal and human MSCs (Radin et al., 2004; Reilly et al., 2007; 
Doostmohammadi et al., 2011; Labbaf et al., 2011). Mesenchymal stem cells are precursors to 
osteoblast cells; hence the effect of BAG particles and dissolution products is critical. 
Therefore, MSCs are an important cell type to use to test the biocompatibility of BAGs. 
However, there is no published information concerning the cytotoxic effect of Ga doped BAG 
particles on the proliferation of human MSCs and or osteoblasts.  
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3.2 AIMS 
 
The aims of this study were to: 
 Investigate and compare the cytotoxic effects of 3 mol% Ga doped BAG and 45S5 
Bioglass® on osteoblasts, using the Saos-2 cell line as a model system. 
 Investigate and compare the effects of 3 mol% Ga doped BAG and 45S5 Bioglass® on 
non-transformed human MSCs. 
 
Several aspects of the activity of both BAGs were tested. These included:  
 Assessment of the effects of the particles (direct contact) of both BAGs with each cell 
type. 
 Assessment of the effects of the dissolution products (indirect contact) of both BAGs 
on each cell type, using media which had been incubated with the BAG particles under 
static and shaker incubation conditions. 
 Assessment of the influence of pH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
~ 114 ~ 
 
 
3.3 METHODSAND MATERIALS 
3.3.1 Glass preparations 
See section 2.3.5 in chapter 2. 
 
3.3.2 pH analysis 
To determine the aqueous pH value of 3 mol% Ga doped BAG and 45S5 Bioglass® at 
concentrations of 2.5 mg/ml, 5 mg/ml and 10 mg/ml, triplicate stock solutions were prepared 
in 5 ml Dulbecco’s modified Eagle’s medium/Ham’s-F12 (DMEM/Ham’s-F12) (PAA, Yeovil, 
Somerset, UK), supplemented with 10% (v/v) foetal bovine serum (FBS) (PAA, Yeovil, 
Somerset, UK), and 1% (v/v) penicillin (50U/ml) and streptomycin (P/S) (50μg/ml). Culture 
media without glass particles served as the control. The stock solutions and controls were 
incubated over night at 37°C in static and shaker (with a shaking speed of 100 rpm) incubators. 
The pH of the stock solutions and controls was measured using the Mettler Toledo pH probe 
(Fisher Scientific, Loughborough, UK) following 24, 48, 72 and 96 hours of incubation. 
 
3.3.3 Determination of Bioactive glass surface characteristics 
Glass cover slips (12mm) (Fisher Scientific, Loughborough, UK) were placed into the wells of 
a 24 well plate (Fisher Scientific, Loughborough, UK), onto which were placed 3 mol% Ga 
doped BAG and 45S5 Bioglass® particles, followed by the addition of 1 ml DMEM /Hams’s-
F12. Following a 24 and 96 hour incubation period at 37°C the culture medium was removed 
from each well, and the particles were washed with PBS (x3) (PAA, Yeovil, Somerset, UK) 
before being dried overnight at 37°C. Following the 24 hour incubation period the glass cover 
slips containing particles were removed and mounted onto stubs, gold-sputtered prior to 
observation with a Carl Zeiss EVO MA10 scanning electron microscope (SEM). 
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3.3.4 Maintenance of mesenchymal stem cell stock culture 
Primary bone marrow derived human mesenchymal stem cells (MSCs) were provided already 
culture-expanded from bone marrow aspirates, by Dr Karina Wright at the Robert and Agnes 
Hunt (RJAH) Orthopaedic Hospital, Oswestry, UK. Bone marrow derived MSCs were cultured 
and maintained in DMEM/Ham’s-F12, supplemented with 10% (v/v) FBS, and 1% (v/v) 
penicillin (50U/ml) and streptomycin (50μg/ml) in a humidified atmosphere at 370C with 5% 
CO2. Upon reaching ~70-75% confluence, cultures were passaged using 0.25% trypsin-1 mM 
EDTA (PAA, Yeovil, Somerset, UK) and a viable cell count was performed by trypan blue 
exclusion (see section 3.3.7). The MSCs for the experiments outlined below were isolated from 
three different donors and were referred to as BMMSC058, BMMSC028 and BMMSC101.  
 
3.3.5 Maintenance of Saos-2 stock cell culture 
Saos-2, (ATCC HTB-85) the human osteosarcoma cell line was cultured and maintained in 
DMEM/Ham’s/F12 supplemented with 10% (v/v) FBS and 1% (v/v) P/S. Cell cultures were 
incubated at 37ºC and 5% CO2. Once the cells became ~70-75% confluent they were passaged 
using 0.25% trypsin-1 mM EDTA and a viable cell count was performed by trypan blue 
exclusion (see section 3.3.7). 
 
3.3.6 Passaging of cells 
Once the cells reached ~70-75% confluency they were trypsinised, this involved washing the 
cells in PBS, which was then discarded.  The cells were then incubated at 37ºC for 5 minutes 
in 0.25% trypsin-EDTA (PAA, Yeovil, Somerset, UK), to lift the cells off the tissue culture 
flask surface. Once the cells had dislodged, culture media was added to stop 0.25% trypsin-
EDTA activity and the resultant dislodged cells were then harvested by centrifugation at 1000 
rpm for 10 minutes. The supernatant was discarded, the resulting pellet was re-suspended in 1 
ml of culture media and a viable cell count was performed by trypan blue exclusion. The cells 
were then either seeded into new tissue culture flasks or used for experiments.  
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3.3.7 Viable cell counts by trypan blue exclusion 
Cell viability was measured by using the trypan blue dye, which only penetrates non-viable 
cells that have perforated cell membranes and as a result the cells appear blue. In order to 
perform a viable cell count, 20µl of cell suspension was added to 20µl of 0.4% (w/v) trypan 
blue solution (Sigma Aldrich, Dorset, UK). This suspension was mixed throughly before being 
loaded onto a haemocytometer (Fisher Scientific. Loughborough, Leicester, UK). The number 
of viable and non-viable cells were then determined. 
 
3.3.8 Characterisation of MSCs  
To verify that the culture-expanded cells were indeed MSCs, phenotypic characterisation was 
performed on BMMSC028 and BMMSC101. Mesenchymal stem cells at passage 4-5 were 
harvested by trypsinisation, centrifuged at 1000 rpm for 10 minutes and re-suspended in PBS 
containing 2% bovine serum albumin (BSA) (Sigma Aldrich, Dorset, UK). Cell count was 
performed via trypan blue exclusion (see section 3.3.7), following which the cells were blocked 
with 10% normal human immunoglobulin (Ig) (Grifols, Cambridge, UK) solution. The cells 
were then incubated with the following phycoerythrin (PE) conjugated mouse monoclonal anti-
human antibodies: CD34, CD45, CD105 (Immunotools, Friesoythe, Germany), CD73 and 
CD90 (BD Biosciences, Oxford, UK) (Dominici et al., 2006). Non-specific fluorescence was 
determined by incubating cells with isotype-matched control PE-conjugated antibodies IgG2a 
and IgG1 (Immunotools, Friesoythe, Germany). The immunoreactivity for each cluster of 
differentiation (CD) surface antigen was measured by flow cytometry using a Beckman Coulter 
FC500 Flow Cytometer and the data was analysed using Kaluza® Analysis 1.3 Software. 
 
3.3.9 Determination of the cytotoxic effects of 3 mol% Ga doped BAG and 45S5 Bioglass® 
on human MSCs and Saso-2 cells.  
3.3.9.1 Direct contact  
To evaluate the cytotoxic effect, MSCs and Saos-2 cells were seeded onto either 3 mol% Ga 
doped BAG or 45S5 Bioglass® UV sterilised (see section 2.3.7.1 of chapter 2) particles. Initially 
for each concentration (2.5 mg/ml, 5 mg/ml, 10 mg/ml and 100 mg/ml), 3 mol% Ga doped 
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BAG and 45S5 BG® particles were placed into triplicate wells of a 24 well plate (Fisher 
Scientific, Loughborough, UK). One ml of DMEM/Hams-F-12 supplemented with 10% (v/v) 
FBS and 1% (v/v) P/S was then added to each well containing glass particles. Bone marrow 
derived MSCs and Saos-2 cells were then seeded at a cell density of 1 x 104 into each well, and 
incubated at 37ºC and 5% CO2 for 96 hours. To visualise the number of viable and non-viable 
cells, LIVE/DEAD staining was performed. The staining solution was prepared with Calcein-
AM and Propidium iodide (Sigma-Aldrich, Dorset, UK) as stated in the manufacturer’s 
instructions. Once the staining solution was prepared, 1 ml was added to each well and the plate 
was incubated at 37ºC for 30 minutes. After 30 minutes the staining solution was removed and 
DMEM/Hams-F-12 culture media was added to the wells. Fluorescence microscopy 
(wavelength of 490 nm) was used to score the number of live (green) and dead (red) cells.  
 
Calcein-AM is highly lipophilic and cell membrane permeable, but is not a fluorescent 
molecule. However, the calcein generated from Calcein-AM by esterase in viable cells emits a 
strong green fluorescence and therefore only stains viable cells. Nuclei staining dye, Propidium 
iodide cannot pass through a viable cell membrane. It enters the cell by passing through 
disordered areas of dead cell membrane, and intercalates with the DNA double helix of the cell 
to emit red fluorescence.  
 
3.3.9.2 Indirect contact 
For the indirect contact experiment, DMEM/Ham’s-F12 culture media supplemented with 10% 
(v/v) FBS and 1% (v/v) P/S was conditioned with the UV sterilised (see section 2.3.7.1 of 
chapter 2) particles of either 3 mol% Ga BAG and 45S5 Bioglass® at the concentration of 2.5 
mg/ml, 5 mg/ml, 10 mg/ml (lower concentrations), 25 mg/ml, 50 mg/ml and 100 mg/ml (higher 
concentrations). The conditioned medium was then incubated at 37°C for 72 hours in either a 
shaking incubator (100 rpm) or a static incubator. After the incubation period, conditioned 
medium was filtered using a 0.45 micron syringe filter (Sartorius Stedim Biotech, Goettingen, 
Germany) and pH readings were recorded using the Mettler Toledo pH probe. The filtered 
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conditioned media was divided equally into two separate sterile universals for each 
concentration. The pH of the media in one of the universals was not neutralised and it remained 
alkaline (pH ranging from 9 to >9), however the pH for the media in the other universal was 
neutralised to a pH of 7.5. This was achieved through the use of pH strips (Life Technologies, 
Paisley, UK) and the addition of 0.1M of HCl (Fisher Scientific, Loughborough, UK). Once 
the neutralisation process was completed, MSCs and Saos-2 cells were harvested via 
trypsinisation (see section 3.3.7). Cell counts were performed via trypan blue exclusion (see 
section 3.3.4), following which the cells were seeded into a 96 well plate (Fisher Scientific, 
Loughborough, UK), containing 200 µls of conditioned DMEM/Ham’s-F12 culture media, at 
a density of 5 x 103 per well of a 96 well plate in triplicates. The cells were incubated at 37ºC 
and 5% CO2 for 96 hours. During the 96 hour period the cells were treated once (at 48 hours) 
with the conditioned DMEM/Ham’s-F12 culture media. Following the 96 hours of incubation, 
cell viability was determined using the MTT test (Milford, Haarlem, Netherlands) assay.  
 
Cell viability was determined using the MTT (Milford, Haarlem, Netherlands) assay. 
NAD(P)H dependent cellular oxidoreductase enzymes present within viable cells reduce the 
tetrazolium dye, MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to 
insoluble formazan crystals. The insoluble formazan is solubilised with dimethyl sulfoxide 
(DMSO) (Sigma Aldrich, Dorset, UK) and the absorbance can be determined as a direct 
measure of cell viability. The MTT solution was prepared on the day of its use. Hundred µl of 
5mg/ml MTT was diluted per 1 ml PBS supplemented with 4.5g/l glucose (Molekula, 
Gillingham, Dorset, UK). Following the 96 hour incubation period, media was removed from 
each well and replaced with 100 µl of PBS/Glucose + MTT solution (Milford, Haarlem, 
Netherlands). The 96 well plate was incubated in the dark at 37oC with 5% CO2 for 4 hours. At 
the end of the incubation period, the solution was carefully removed and the plate was left to 
air dry for 10 minutes. Hundred µl of DMSO (Sigma-Aldrich, UK) was added to each well and 
the plate was mixed for 20 seconds on a shaker to dissociate cell debris. The absorbance was 
read using an Ascent MultiScan FX Spectrophotometer (Fisher Scientific, Loughborough, UK) 
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at 590nm and background at 690nm. The absorbance values obtained were corrected for 
background and normalised to the control. 
 
3.3.10 To investigate the effect of the dissolution products of 3 mol% Ga doped BAG and 
45S5 Bioglass® on cellular adhesion and morphology.  
Stock solutions were prepared for UV sterilised (see section 2.3.7.1 of chapter 2) 3 mol% Ga 
doped BAG and 45S5 Bioglass at 2.5 mg/ml, 5 mg/ml and 10 mg/ml in DMEM/Ham’s-F12 
culture media supplemented with 10% (v/v) FBS and 1% (v/v) P/S. Culture medium without 
particles served as the control. The stock solutions and controls were incubated at 37°C in a 
static incubator and shaker (100 rpm) incubator for 72 hours. Following 72 hour incubation 
period the stock solutions were filtered using a 0.45 micron syringe filter and pH values 
measured using a Mettler Toledo pH probe. Refer to section 3.3.9.2 for the neutralisation of 
the filtered conditioned media. Once the neutralisation process was completed, MSCs and 
Saos-2 cells were harvested via trypsinisation (see section 3.3.7). Cells were seeded at a density 
of 5 x 103 per well of a 96 well plate in triplicate. The cells were incubated at 37ºC and 5% CO2 
for 96 hours. During the 96 hour period the cells were treated once (at 48 hours) with 
conditioned DMEM/Ham’s-F12 culture media. At 96 hours phase contrast images were taken 
using a Jenoptik ProgRes CF Microscope (Microscope World, Carlsbad, USA). 
 
3.3.11 Statistical analysis 
Two-way ANOVA was carried out to determine statistical significances (GraphPad 
Prism 6.0). If a significant difference was detected a Tukey test and a Sidak’s test were 
carried out to determine which values were significantly different. Differences were 
considered statistically significant at a level of P < 0.05.  
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3.4 RESULTS  
3.4.1 Characterisation of MSCs. 
To confirm that the culture-expanded bone marrow MSCs maintained their phenotype, they 
were stained for a set of cell surface (CD) markers. As shown in figure 3.1, the majority of the 
MSCs were positive for CD73 (88.0% ± SD 9.19), CD90 (87.8% ± SD 12.0) and CD105 
(90.7% ± SD 1.37), but were negative for CD34 (99.5% ± SD 0.04) and CD45 (99.4% ± SD 
0.07), suggesting that the culture-expanded MSCs were not of haematopoietic origin and had 
pluripotent differentiation potential. Therefore, under the right conditions they could 
differentiate into osteoblasts, chondrocytes and adipocytes.  
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Figure 3.1 The CD profile of MSCs. MSCs were subjected to flow cytometry analysis after 
they were stained with antibodies for the negative CD markers CD34 and CD45 (top), and 
positive markers CD73 (middle), CD90 and CD105 (bottom). In each histogram the isotype-
control Ig are shown in grey, and the CD marker in white. 
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~ 122 ~ 
 
3.4.2 Surface characteristics of 3 mol% Ga doped BAG and 45S5 Bioglass® particles 
Figure 3.2 shows the SEM images of 3 mol% Ga doped BAG and 45S5 Bioglass® particles. 
The particles of both 3 mol% Ga doped BAG and 45S5 Bioglass® appear to be angular and 
irregular shaped. The surfaces of unreacted 45S5 Bioglass® and 3 mol% Ga doped BAG 
particles in figure 3.2 (A and D) appear smooth and are covered by flakes of smaller particles. 
Figures 3.2B and 3.2E show the surfaces of 45S5 Bioglass® and 3 mol% Ga doped BAG, 
respectively, revealing a relatively smooth surface with smaller particles scattered on top. 
Following 96 hours of soaking, the presence of small nodule-like speckles can be seen on the 
surface of 45S5 Bioglass® (Figure 3.2C). Figure 3.2F shows the surface of 3 mol% Ga doped 
BAG after 96 hour immersion in DMEM/Ham’s-F12 culture media, revealing a smooth surface 
peppered with smaller particles.     
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Figure 3.2 SEM images of the surfaces of (A) 45S5 Bioglass® particles at 0 hours at 5.00 kV 
and WD = 9.5 mm, (B) 45S5 Bioglass® particles after soaking in DMEM/Ham’s-F12 media 
for 24 at 15.00 kV and WD = 5 mm, and (C) 96 hours at 10.95 kV and WD = 6.5 mm, (D) 3 
mol% Ga doped BAG at 0 hours at 5.00 kV and WD = 8.00 mm, (E) 3 mol% Ga doped BAG 
particles after soaking in DMEM/Ham’s-F12 media for 24 at 15.00 kV and WD = 4.5 mm, and 
(F) 96 hours at 10.95 kV and WD = 4.5 mm. Bar represents 2µm.  
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3.4.3 The cytotoxic effect of 3 mol% Ga doped BAG and 45S5 Bioglass® at concentrations 
25 - 100 mg/ml on Saos-2 cell viability. 
LIVE/DEAD staining was performed to evaluate the cytotoxic effects of 3 mol% Ga doped 
BAG and 45S5 Bioglass® particles. Following exposure to the particles over a 96 hour period, 
viable (green) and non-viable (red) Saos-2 cells could not be seen on the particles, which 
appeared to have taken up the staining solution (see figure A.3 in appendix).  
 
MTT assay was performed to assess Saos-2 cell viability following exposure to higher 
concentrations of 45S5 Bioglass® and 3 mol% Ga doped BAG dissolution products. The results 
were calculated as percentages of respective controls. As shown in figure 3.3 the dissolution 
products of 45S5 Bioglass® and 3mol% Ga doped BAG demonstrated a significant cytotoxic 
effect against Saso-2 cells in comparison to the non-treated control. At all the concentrations 
tested 45S5 Bioglass® exhibited significant cytotoxicity (p = < 0.0001) with cell viability of 
16.9%, 9.08%, and 7.91% for 25mg/ml, 50 mg/ml and 100 mg/ml, respectively. Dissolution 
products of 3 mol% Ga doped BAG (p = < 0.0001) were similar to 45S5 Bioglass® in their 
action, with cell viability of 13.8%, 5.87% and 6.89% at 25 mg/ml, 50 mg/ml and 100 mg/ml, 
respectively. No statistical significant difference was observed between 45S5 Bioglass® and 3 
mol% Ga doped BAG at all concentrations tested. 
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Figure 3.3 The effect of the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped 
BAG on Saos-2 cells. MTT assays were used to assess Saos-2 cell viability following 96 hours 
incubation in BAG conditioned medium. Data shown are expressed as means ± SD (n=3) and 
reported at a significant level of p < 0.0001 (****). 
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3.4.4 pH analysis of 3 mol% Ga doped BAG and 45S5 Bioglass® at concentrations 2.5-10 
mg/ml  
pH values of DMEM/Hams-F12 culture medium containing either 45S5 Bioglass® or 3 mol% 
Ga doped BAG particles increased with the increase of particle concentration under both static 
(Figure 3.4) and shaker (Figure 3.5) incubation conditions. Culture medium containing 45S5 
Bioglass® showed a statistically significant (p = < 0.0001) rise in pH, which increased to 8.6 (± 
SEM 0.08), 8.6 (± SEM 0.14) and 9.2 (± SEM 0.03) for 2.5, 5 and 10 mg/ml concentrations, 
respectively, after 24 hours under static incubation conditions. Similarly, pH values for 
DMEM/Hams-F12 media containing 3 mol% Ga doped BAG particles also significantly (p = 
< 0.0001) increased to 8.5, 8.6 and 9.1 for 2.5, 5 and 10 mg/ml concentrations, respectively, in 
comparison to culture medium without particles at 24 hours. A further increase in pH was not 
observed for either 45S5 Bioglass® or 3 mol% Ga doped BAG particles after the initial increase 
reported at 24 hours for static incubation conditions. 
 
Under shaker incubation conditions, pH values of the variable concentrations tested increased. 
The pH values significantly (p = < 0.0001) increased to 9.0, 9.4, and 9.5 for 45S5 Bioglass® 
particle concentrations 2.5, 5 and 10 mg/ml, respectively, after 24 hours. Likewise, 3 mol% Ga 
doped BAG particles also significantly (p = 0.0001) increased the pH of the culture medium to 
8.9, 9.2 and 9.5 for 2.5, 5 and 10 mg/ml concentrations.  
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Figure 3.4 pH analysis of variable concentrations of (A) 45S5 Bioglass® and (B) 3 mol% Ga 
doped BAG particles immersed in DMEM/Ham’s-F12 media over a 96 hour period, under 
static incubation conditions. Data shown are expressed as means ± SD (n=2).  
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Figure 3.5 pH analysis of variable concentrations of (A) 45S5 Bioglass® and (B) 3 mol% Ga 
doped BAG particles immersed in DMEM/Ham’s-F12 media over a 96 hour period, under 
shaker incubation conditions. Data shown are means ± SD (n=2).  
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3.4.5 Direct contact of 3 mol% Ga doped BAG and 45S5 Bioglass® particles at 
concentrations 2.5 – 10 mg/ml with Saos-2 cells and MSCs 
3.4.5.1 Saos-2 cells 
The viability of Saos-2 cells was compromised as the concentration of 45S5 Bioglass® and 3 
mol% Ga doped BAG particles increased. A high number of cells in group’s 0mg/ml, 2.5 mg/ml 
and 5 mg/ml were stained with Calcein-AM (green – live) with very few cells stained with 
Propidium iodide (red – dead). However, at 10 mg there were a higher number of cells stained 
with Propidium iodide. This was observed for 45S5 Bioglass® (Figure 3.6) and 3 mol% Ga 
doped BAG (Figure 3.7) after 96 hours.  
 
Figure 3.8 also shows that 2.5 mg/ml was the most effective concentration for both 45S5 
Bioglass® (Figure 3.4A) and 3 mol% Ga doped BAG (Figure 3.4B) particles, with a viability of 
90.4%  and 85.1%, respectively. Moreover, 5 mg/ml of 45S5 Bioglass® exhibited a similar 
effect, as a significant difference (p = 0.05) was observed between 0 mg/ml.  A statistically 
significant reduction in the viability of Saos-2 cells was observed after exposure to 3 mol% Ga 
doped BAG (p = < 0.001) particles at 10 mg/ml, compared to 0 mg/ml. The percentage viability 
at 10 mg/ml for 3 mol% Ga doped BAG particles was 51.2%, whereas for 45S5 Bioglass® 
particles was 61.4%.  
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Figure 3.6 Same field of view fluorescent microscopy images at x10 objective are shown for 
LIVE/DEAD staining of Saos-2 cells cultured with and without 45S5 Bioglass® particles at 
variable concentrations for 96 hours.  Green indicates live cells and red dead cells. Bar indicates 
100 µm. 
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Figure 3.7 Same field of view fluorescent microscopy images at x10 objective are shown for 
LIVE/DEAD staining of Saos-2 cells cultured with and without 3 mol% Ga doped BAG 
particles at variable concentrations, for 96 hours. Live cells are green and dead cells are red. 
Bar indicates 100µm.  
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Figure 3.8 The proportion of viable and non-viable cells were determined following 
LIVE/DEAD staining of Saos-2 cells cultured with  45S5 Bioglass®  and  3 mol% Ga doped 
BAG particles at variable concentrations, over a 96 hour incubation period. Viable cells of 
Saos-2 cells cultured with (A) 45S5 Bioglass® and (B) 3 mol% Ga doped BAG particles. Data 
shown are expressed as means ± SD (n=3) and reported at a significant level of p = < 0.05 (*). 
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3.4.5.2 MSCs 
LIVE/DEAD staining demonstrated that particles of 45S5 Bioglass® (Figure 3.9) and 3 mol% 
Ga doped BAG (Figure 3.10) were non-cytotoxic with live (green) cells visible in all 
concentrations with very few dead (red) cells, after 96 hours in culture. However, figure 3.11 
shows a slight but progressive reduction in MSC viability with increasing particle 
concentration for both 45S5 Bioglass® (Figure 3.11A) and 3 mol% Ga doped BAG (Figure 
3.11B). Despite the slight reduction in cell viability no statistical significance was observed. 
Nevertheless at 10 mg/ml the percentage of viable MSCs following exposure to 45S5 Bioglass® 
particles was 73.2% and a similar effect was exhibited by 3 mol% Ga doped BAG particles, 
with a cell viability percentage of 73.3%. 
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Figure 3.9 Same field of view fluorescent microscopy images at x10 objective are shown for 
LIVE/DEAD staining of MSCs cells cultured with and without 45S5 Bioglass® particles for 96 
hours.  Live cells are green and dead cells are red. Bar indicates 100µm. 
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Figure 3.10 Same field of view fluorescent microscopy images are shown for LIVE/DEAD 
staining of MSCs cells cultured with variable concentrations and without 3 mol% Ga doped 
BAG particles, for 96 hours.  Live cells are green and dead cells are red. Bar indicates 100µm. 
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Figure 3.11 The proportion of viable or non-viable cells were determined following 
LIVE/DEAD staining of MSCs cultured with 45S5 Bioglass® and 3 mol% Ga doped BAG 
particles at variable concentration, over a 96 hour incubation period. Viable cells of MSCs 
cultured with (A) 45S5 Bioglass® and, (B) 3 mol% Ga doped BAG particles. Data shown are 
expressed as means ± SD (n=3).  
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3.4.6 Cytotoxic effect of 3 mol% Ga doped BAG and 45S5 Bioglass® dissolution products 
at concentrations 2.5 -10 mg/ml on Saos-2 cell and MSC viability 
3.4.6.1 The cytotoxic effect of the dissolution products of 3 mol% Ga doped BAG and 
45S5 Bioglass® on Saos-2 cells  
The MTT assay was used to assess the viability of Saos-2 cells cultured in 45S5 Bioglass® and 
3 mol% Ga doped BAG conditioned medium generated under static and shaker incubating 
conditions. The results were calculated as percentages of respective controls. As shown in 
figure 3.12 (A) under static incubation conditions the dissolution products of 45S5 
Bioglass® and 3 mol% Ga doped BAG were cytotoxic, with 45S5 Bioglass® exhibiting greater 
cytotoxicity. A statistical significant reduction in Saos-2 cell viability was observed following 
exposure to 45S5 Bioglass® (p = 0.05) and 3 mol% Ga doped BAG (p = 0.05) dissolution 
products at 10 mg/ml, compared to control (0 mg/ml). The percentage viability at 10 mg/ml for 
45S5 Bioglass® was 67%, and for 3 mol% Ga doped BAG 68.6%. 
 
The dissolution products from 45S5 Bioglass® and 3 mol% Ga doped BAG conditioned 
DMEM/Ham’s-F12 culture medium generated under shaker incubating conditions decreased 
the number of viable Saos-2 cells (Figure 3.12B). Moreover, the cytotoxicity of the dissolution 
products was concentration dependent, as the highest concentration of 10 mg/ml exhibited the 
strongest cytotoxic effect. A statistically significant reduction in Saos-2 cell viability was 
observed after exposure to the dissolution products of 45S5 Bioglass® at 10 mg/ml with a cell 
viability of 4.78% (p = 0.0001), whilst 18.4%  (p = 0.0001) was observed for 3 mol% Ga doped 
BAG, compared to the control. The dissolution products of 45S5 Bioglass® (p = 0.001) 
demonstrated a greater cytotoxic effect with a cell viability of 38.4% whereas 72.7% was 
observed for 3 mol% Ga doped BAG, at 5 mg/ml.  
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Figure 3.12 The effect of the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped 
BAG on Saos-2 cells. MTT assays were used to assess Saos-2 cell viability following 96 hours 
incubation in BAG conditioned medium generated under static (A) and shaker (B) incubating 
conditions. Data shown are expressed as means ± SD (n=3) and reported at a significant level 
of p = 0.05 (*), p = 0.0097 (**), p = 0.0009 (***) and p = 0.0001 (****). 
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3.4.6.2 The cytotoxic effect of pH neutralised dissolution products of 3 mol% Ga doped 
BAG and 45S5 Bioglass® on Saos-2 cells 
Following pH neutralisation of conditioned DMEM/Ham’s-F12 culture medium, which had 
been generated in a static incubator the dissolution products of 45S5 Bioglass® and 3 mol% Ga 
doped BAG were non-cytotoxic at the concentrations tested (Figure 3.13A). The dissolution 
products of 45S5 Bioglass® at 2.5 mg/ml increased (p = 0.03) cell viability, which was 108.3 
%, whereas cell viability of 88% in comparison to the non-treated control was observed for the 
dissolution products of 3 mol% Ga doped BAG.  
 
The pH neutralisation of conditioned culture medium generated under shaker incubating 
conditions, which consisted of dissolution products from 45S5 Bioglass® and 3 mol% Ga doped 
BAG demonstrated a cytotoxic effect at 10 mg/ml (Figure 3.13B). 45S5 Bioglass® dissolution 
products exhibited a slightly greater cytotoxicity with cell viability of 30.8%, than 3 mol% Ga 
doped BAG dissolution products (46.1%). Although, no statistical significant difference was 
observed the cytotoxic effect of the dissolution products on Saos-2 cells appeared to be 
concentration dependent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
~ 140 ~ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13 The effect of dissolution products of 45S5 Bioglass® and 3 mol% Ga doped BAG 
following pH neutralisation on Saos-2 cells. MTT assays were used to assess Saos-2 cell 
viability following 96 hours incubation in BAG conditioned medium generated under static 
(A) and shaker (B) incubating conditions. . Data shown are expressed as means ± SD (n=3) 
and are reported at a significant level of p = 0.03 (*), and p = 0.001 (**).  
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3.4.6.3 The cytotoxic effect of the dissolution products of 3 mol% Ga doped BAG and 
45S5 Bioglass® on MSCs 
Under static incubating conditions the culture medium generated with dissolution products 
from 45S5 Bioglass® and 3 mol% Ga doped BAG demonstrated a concentration dependent 
cytotoxic effect on MSC viability (Figure 3.14A). A statistically significant reduction (p = 
0.05) in the viability of MSCs was observed after exposure to the dissolution products of 45S5 
Bioglass® at 10 mg/ml, compared to the non-treated control. Although, no statistical significant 
difference was observed between 45S5 Bioglass® and 3 mol% Ga doped BAG dissolution 
products at 10 mg/ml, the dissolution products of 45S5 Bioglass® exhibited greater cytotoxicity 
with a cell viability of 46.6%, whilst the cell viability observed for 3 mol% Ga doped BAG 
was 58%.  
 
Culture medium consisting of dissolution products from 45S5 Bioglass® and 3 mol% Ga doped 
BAG generated under shaker incubation conditions demonstrated a concentration dependent 
cytotoxicity (Figure 3.13B). At the highest concentration tested, 10 mg/ml exhibited 
statistically significant cytotoxicity for both 45S5 Bioglass® (p = 0.001) and 3 mol% Ga doped 
BAG (p = 0.01), compared to 0 mg/ml. Additionally, the dissolution products of 45S5 
Bioglass® and 3 mol% Ga doped BAG at 5 mg/ml also demonstrated a statistical significance 
of p = 0.05, compared to 0 mg/ml. Despite no statistical significant difference being observed 
between the two glass groups, 45S5 Bioglass® (p = 0.001) demonstrated greater cytotoxicity at 
10 mg/ml with a reduction in cell viability of 16.4%, whilst 3 mol% Ga doped BAG (p = 0.01) 
displayed a cell viability of 33.5%.  
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Figure 3.14 The effect of the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped 
BAG on MSCs cells. MTT assays were used to assess MSCs viability following 96 hours 
incubation in BAG conditioned medium generated under static (A) and shaker (B) incubating 
conditions. Data shown are expressed as means ± SD (n=3) and reported at a significant level 
of p 0.05 (*), p = 0.01 (**) and p = 0.001 (***). 
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3.4.6.4 The cytotoxic effect of pH neutralised dissolution products of 3 mol% Ga doped 
BAG and 45S5 Bioglass® on MSCs 
As shown in figure 3.15 (A) the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped 
BAG conditioned medium generated under static incubating conditions, demonstrated a non-
cytotoxic effect on MSCs. The viability of MSCs significantly increased at 2.5 mg/ml and 5 
mg/ml for 45S5 Bioglass® with cell viability of 151.9% and 125.7%, respectively. Additionally, 
statistical significance (p = 0.05) was observed between 2.5 mg/ml and the higher 
concentrations. The dissolution products of 3 mol% Ga doped BAG did not increase the 
viability of MSCs however they also did not exhibit cytotoxicity at the lower concentrations 
tested. 3 mol% Ga doped BAG demonstrated cytotoxicity at the highest concentration of 10 
mg/ml in comparison to the non-treated control, with cell viability of 71.3%, whereas a 
reduction in cell viability of 89.8% was observed for 45S5 Bioglass®.  
 
Figure 3.15 (B) demonstrates that the cytotoxic effect of 45S5 Bioglass® and 3 mol% Ga doped 
BAG dissolution products present in conditioned culture media generated under shaker 
incubating conditions, had a concentration dependent cytotoxic effect on MSCs. 2.5 mg/ml 
exhibited the least cytotoxic effect with a cell viability of 105.1% and 106.5% for 45S5 
Bioglass® and 3 mol% Ga doped BAG, respectively. However, a statistically significant 
reduction in MSCs viability was observed at 10 mg/ml for 45S5 Bioglass® (p = 0.05) and 3 
mol% Ga doped BAG (p = 0.01), compared to 0 mg/ml. Furthermore, at 10 mg/ml 3 mol% Ga 
doped BAG dissolution products exerted a slightly greater cytotoxic effect than 45S5 Bioglass® 
with a cell viability of 48.8% and 59.9%, respectively.  
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Figure 3.15 The effect of dissolution products of 45S5 Bioglass® and 3 mol% Ga doped BAG 
following pH neutralisation on MSCs. MTT assays were used to assess Saos-2 cell viability 
following 96 hours incubation in BAG conditioned medium generated under static (A) and 
shaker (B) incubating conditions. Data shown are expressed as means ± SD (n=3) and reported 
at a significant level of p 0.05 (*) and p 0.01 (**). 
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3.4.7 Cell Morphology and adhesion studies – at concentrations 2.5-10 mg/ml 
3.4.7.1 The effect of the dissolution products from 3 mol% Ga doped BAG and 45S5 
Bioglass® on Saos-2 cells 
The morphology and the shape of Saos-2 cells cultured with the dissolution products of 45S5 
Bioglass® and 3 mol% Ga BAG were examined by light microscopy. The conditioned culture 
medium with the dissolution products of 45S5 Bioglass® and 3 mol% Ga doped BAG was 
generated under static and shaker incubating conditions. Figures 3.16 and 3.17 show that as the 
concentration of the dissolution products from both glasses increased, the typical cube shape 
of Saos-2 cells transformed into a rounded shape and detached themselves from the surface of 
the well. This transformation appears more prominent for Saos-2 cells treated with culture 
media conditioned with 10 mg/ml of 45S5 Bioglass® and 3 mol% Ga doped BAG under shaker 
incubation conditions. As the concentration of the dissolution products increased, the number 
of viable cells viewed under the microscope decreased, compared to the non-treated control.  
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Figure 3.16 Phase contrast images at x10 objective of Saos-2 cells treated with 45S5 Bioglass® 
conditioned media following a 96 hour incubation period. Saos-2 cells were treated with 
conditioned media generated under static incubation conditions at 0 mg/ml (A), 2.5 mg/ml (B), 
5 mg/ml (C) and 10 mg/ml (D). Saos-2 cells were treated with conditioned media generated 
under shaker incubation conditions at 0 mg/ml (E), 2.5 mg/ml (F), 5 mg/ml (G) and 10 mg/ml 
(H). Bar indicates 100µm. 
 
 
 
 
A 
C 
B 
D 
E 
F 
G 
H 
~ 147 ~ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17 Phase contrast images at x10 objective of Saos-2 cells treated with 3 mol% Ga 
doped BAG conditioned media following a 96 hour incubation period. Saos-2 cells were treated 
with conditioned media generated under static incubation conditions at 0 mg/ml (A), 2.5 mg/ml 
(B), 5 mg/ml (C) and 10 mg/ml (D). Saos-2 cells were treated with conditioned media 
generated under shaker incubation conditions at 0 mg/ml (E), 2.5 mg/ml (F), 5 mg/ml (G) and 
10 mg/ml (H). Bar indicates 100µm. 
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3.4.7.2 The effect of pH neutralised dissolution products of 3 mol% Ga doped BAG and 
45S5 Bioglass® on Saos2 cells 
Following pH neutralisation of culture medium conditioned with 45S5 Bioglass® and 3 mol% 
Ga doped BAG, generated under static and shaker incubating conditions; the media was used 
to treat Saos-2 cells for 96 hours. Figures 3.18 and 3.19 demonstrate that the morphology of 
Saos-2 cells cultured with conditioned media generated under static incubation conditions was 
similar to Saos-2 cells treated with media without dissolution products. However, an increase 
in the concentration of the dissolution products resulted in a progressive reduction of viable 
cells.  
The lower concentrations of 45S5 Bioglass® and 3 mol% Ga doped BAG conditioned culture 
medium generated under shaker incubation conditions did not affect the morphology of Saos-
2 cells. At 10 mg/ml predominantly non-viable Saos-2 cells were observed which appeared 
rounded in shape and had detached from the well.  
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Figure 3.18 Phase contrast images at x10 objective of Saos-2 cells treated with 45S5 Bioglass® 
conditioned media following pH neutralisation, over a 96 hour incubation period. Saos-2 cells 
were treated with conditioned media generated under static incubation conditions at 0 mg/ml 
(A), 2.5 mg/ml (B), 5 mg/ml (C) and 10 mg/ml (D). Saos-2 cells were treated with conditioned 
media generated under shaker incubation conditions at 0 mg/ml (E), 2.5 mg/ml (F), 5 mg/ml 
(G) and 10 mg/ml (H). Bar indicates 100µm. 
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Figure 3.19 Phase contrast images at x 10 objective of Saos-2 cells treated with 3 mol% Ga 
doped BAG conditioned media following pH neutralisation, over a 96 hour incubation period. 
Saos-2 cells were treated with conditioned media generated under static incubation conditions 
at 0 mg/ml (A), 2.5 mg/ml (B), 5 mg/ml (C) and 10 mg/ml (D). Saos-2 cells were treated with 
conditioned media generated under shaker incubation conditions at 0 mg/ml (E), 2.5 mg/ml 
(F), 5 mg/ml (G) and 10 mg/ml (H). Bar indicates 100µm. 
 
 
 
A 
B 
C 
D 
E 
F 
G 
H 
~ 151 ~ 
 
3.4.7.3 The effect of the dissolution products from 3 mol% Ga doped BAG and 45S5 
Bioglass® on MSCs  
Bone marrow derived MSCs cultured in 45S5 Bioglass® and 3 mol% Ga doped BAG 
conditioned culture medium generated under static incubating conditions had a similar 
morphology of long, thin, and widely dispersed, to MSCs cultured in the absence of dissolution 
products (Figures 3.20 and 3.21). Bone marrow MSCs cultured in lower concentrations of 
shaker conditioned medium of 45S5 Bioglass® and 3 mol% Ga doped BAG also presented a 
similar morphology as the MSCs grown in 0 mg/ml. The highest concentration of conditioned 
culture media for both 45S5 Bioglass® and 3 mol% Ga doped BAG reduced the number of 
viable MSCs, which appeared rounded. Additionally, extremely thin MSCs not widely 
dispersed were also observed at 10 mg/ml for both 45S5 Bioglass® and 3 mol% Ga BAG 
conditioned media, generated under shaker incubating conditions.  
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Figure 3.20 Phase contrast images at x10 objective of MSCs treated with 45S5 Bioglass® 
conditioned media following a 96 hour incubation period. MSCs were treated with conditioned 
media generated under static incubation conditions at 0 mg/ml (A), 2.5 mg/ml (B), 5 mg/ml 
(C) and 10 mg/ml (D). MSCs were treated with conditioned media generated under shaker 
incubation conditions at 0 mg/ml (E), 2.5 mg/ml (F), 5 mg/ml (G) and 10 mg/ml (H). Bar 
indicates 100µm. 
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Figure 3.21 Phase contrast images of MSCs treated with 3 mol% Ga doped BAG on BMMSC 
conditioned media following a 96 hour incubation period. MSCs were treated with conditioned 
media generated under static incubation conditions at 0 mg/ml (A), 2.5 mg/ml (B), 5 mg/ml 
(C) and 10 mg/ml (D). MSCs were treated conditioned media generated under shaker 
incubation conditions at 0 mg/ml (E), 2.5 mg/ml (F), 5 mg/ml (G) and 10 mg/ml (H) of. Bar 
indicates 100µm. 
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3.4.7.4 The effect of pH neutralised dissolution products of 3 mol% Ga doped BAG and 
45S5 Bioglass® on MSCs 
The morphology of MSCs cultured in 45S5 Bioglass® and 3 mol% Ga doped BAG conditioned 
media generated under shaker incubation conditions, at 10 mg/ml appeared extremely thin and 
were not widely dispersed (Figures 22 and 23). Furthermore, a reduction in size and number 
was also observed. However, MSCs treated with the lower concentrations had a similar 
morphology to those grown in 0 mg/ml. Bone marrow MSCs treated with 45S5 Bioglass® and 
3 mol% Ga doped BAG conditioned media generated under static incubation conditions, 
retained their typical long and thin morphology, even at the highest concentration of 10 mg/ml.  
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Figure 3.22 Phase contrast images at x10 objective of MSCs treated with 45S5 Bioglass® 
conditioned media following pH neutralisation over a 96 hour incubation period. MSCs were 
treated with conditioned media generated under static incubation conditions at 0 mg/ml (A), 
2.5 mg/ml (B), 5 mg/ml (C) and 10 mg/ml (D). MSCs were treated with conditioned media 
generated under shaker incubation conditions at 0 mg/ml (E), 2.5 mg/ml (F), 5 mg/ml (G) and 
10 mg/ml (H). Bar indicates 100µm. 
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Figure 3.23 Phase contrast images at x10 objective MSCs treated with 3 mol% Ga doped BAG 
conditioned media following pH neutralisation after 96 hour incubation period. MSCs were 
treated with conditioned media generated under static incubation conditions at 0 mg/ml (A), 
2.5 mg/ml (B), 5 mg/ml (C) and 10 mg/ml (D). MSCs were treated with conditioned media 
generated under shaker incubation conditions at 0 mg/ml (E), 2.5 mg/ml (F), 5 mg/ml (G) and 
10 mg/ml (H). Bar indicates 100µm. 
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3.5 DISCUSSION  
Osteogenesis is not only dependent upon the action of BAG dissolution products on 
osteoprogenitor cells, but also on the formation of a HCA layer, which provides a surface 
suitable for osteogenic cell attachment and proliferation. Bone bonding to the HCA layer is 
thought to involve protein adsorption, cell attachment, cell proliferation and differentiation, 
secretion of extracellular matrix and its mineralisation (Jones, 2013). Matsuura et al. (2000) 
reported that serum proteins such as vitronectin and fibronectin were adsorbed onto 
hydroxyapatite discs that mediated osteoblast adhesion onto the hydroxyapatite surface. In 
vitro studies have demonstrated that 45S5 Bioglass® and Ga doped BAG do form a HCA layer 
(Sepulveda et al., 2001; Jones et al., 2001; Franchini et al., 2012; Lusvardi et al., 2013).  
 
In this study the cytotoxic effects of 3 mol% Ga doped BAG particles on the growth and 
viability of human bone marrow derived MSCs and osteoblast-like Saos-2 cells were 
investigated. Although the osteogenic effects of 45S5 Bioglass® are well established, the 
cytotoxic effects of 45S5 Bioglass® were also investigated and compared. Initially, the 
concentrations chosen were 25 mg/ml, 50 mg/ml and 100 mg/ml based on existing literature, 
which reported that BAGs at these concentrations exhibited antibacterial efficacy against a 
range of pathogens. Even though these concentrations were found to exhibit antibacterial 
efficacy against E. coli (see chapter 2) they were also cytotoxic. The dissolution products at 25 
mg/ml, 50 mg/ml and 100 mg/ml significantly reduced Saos-2 cell viability in comparison to 
non-treated cells, for both BAGs. Furthermore, viable and non-viable cells could not be 
observed via LIVE/DEAD staining following exposure to 3 mol% Ga doped BAG and 45S5 
Bioglass® particles. The prevention of bacterial colonisation is essential for the survivability of 
orthopaedic implants, but not at the expense of damaging host cells. Therefore, lower 
concentrations (2.5 mg/ml, 5 mg/ml and 10 mg/ml) were chosen in the hope that the BAGs 
would maintain their antibacterial properties without adverse effects on human cells. 
Henceforth, results obtained with the lower concentrations will be discussed. 
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The results for the direct contact experiments, where 1 x 104 MSCs and Saos-2 cells were 
seeded onto varying concentrations of both 45S5 Bioglass® and 3 mol% Ga doped BAG 
particles, demonstrated that cell viability of both cell types was dependent on concentration.  
An increase in particle concentration resulted in decreased number of viable (green) cells 
assessed by LIVE/DEAD staining (figures 3.6, 3.7, 3.9 and 3.10). This decrease in cell viability 
could be attributed to the decreased formation of a HCA layer in solution. Jones et al., (2001) 
found that as 45S5 Bioglass® concentration increased the concentration of active ions increased 
but the rate of HCA layer formation decreased, and instead calcium carbonate (calcite) was 
detected on the surface. Calcite formation is due to the increased calcium to phosphorous ratio, 
which causes an increase in pH of the solution (Jones et al., 2001; Sepulveda et al., 2001).   
 
In vitro studies have reported HCA (apatite like) formation on the surface of 45S5 Bioglass® 
following 22 hours of soaking in stimulated body fluid (SBF) and minimum essential medium 
alpha medium (αMEM) supplemented with 10% FBS and 1% penicillin and streptomycin 
(Jones et al., 2001; Sepulveda et al., 2001), however in this study the SEM images show that 
no significant differences were observed between the dry 45S5 Bioglass® particles and those 
immersed in DMEM-Hams/F12 media for 24 hours. At 96 hours small nodules can be seen on 
the surface of 45S5 Bioglass® particles, which could be HCA formation or calcite as the 
concentration of the particles immersed in media was the highest concentration tested, 10 
mg/ml. Additionally, the particles of 3 mol% Ga doped BAG did not exhibit surface changes, 
and the changes observed at 24 hours were similar to those at 96 hours. In fact Franchini et al. 
(2012) and Lusvardi et al. (2013) reported that HCA formation on Ga3+ doped BAG took as 
long as 30 days, due to the slow release of Ca2+ ions from the glass system.  
 
Cell adhesion is an essential process involved in cell proliferation, cell migration and cell 
differentiation (Anselme et al., 1999). Due to the slow changes observed on the surfaces of 
both 45S5 Bioglass® and 3 mol% Ga doped BAG it is possible that MSCs and Saos-2 cells 
seeded onto the particles were unable to form a strong attachment. Gough et al. (2003) found 
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that a rough Bioglass® surface was conducive for osteoblast attachment and mineralised nodule 
formation, which they attributed to the rapid HCA formation. Furthermore, melt-derived 
powders of 45S5 Bioglass® exhibit very little porosity (Sepulveda et al., 2001). Porous 
scaffolds are necessary for bone formation because they allow migration and proliferation of 
osteoblasts and MSCs (Karageorgiou et al., 2005). Highly porous materials promote a higher 
degree of hydroxylation of the surface forming SiOH (silica-rich gel layer), which provides 
more sites for calcium phosphate layer nucleation (Sepulveda et al., 2001; Sepulveda et al., 
2001).   
 
These findings contradict those of Price et al. (2010) and Mayr-Wohlfart et al. (2001) who 
have demonstrated good proliferation rate of osteoblast-like cells when cultured on Bioglass®. 
These authors seeded osteoblast-like cells onto Bioglass® discs, which exhibit a slower 
dissolution rate due to the small surface area, whereas particles exhibit higher surface areas and 
therefore provide more exposed surface for dissolution (Sepulveda et al., 2001). A higher 
dissolution rate results in faster release of dissolution products Ca2+ and Na+ ions from the glass, 
which were present as network modifiers in both 45S5 Bioglass® and 3mol% Ga doped BAG, 
and thus leading to increased pH values. An increasing pH can affect cell growth, which could 
explain the reduced cell viability observed at higher glass concentrations. The pH increased 
(ranging from 8 to 9) as glass concentration increased because of the greater quantities of 
cations released from the glass systems.  
 
It was found that 3 mol% Ga doped BAG was slightly more cytotoxic in its action, particularly 
against Saos-2 cells at 10 mg/ml (Figure 3.8). This could be attributed to the leaching of Ga3+ 
ions from the 3 mol% Ga doped BAG, which are known to possess antineoplastic and anti-
proliferative properties (Chitamber, 2010). Gallium’s antineoplastic activity has been attributed 
to its ability to bind to the iron-transport proteins transferrin (Tf), as well as lactoferrin and 
ferritin, enabling it to accumulate in proliferating tissue (including most tumours) where large 
amounts of Tf receptors (TfR) are expressed (Lessa et al., 2012; Daniels et al., 2006). 
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Internalisation of Ga-Tf complexes via TfR by cells leads to iron deprivation, which ultimately 
prevents cell division and may lead to apoptosis (Bernstein, 1998; Lessa et al., 2012). This 
could explain as to why reduced cell viability was observed for Saos-2 cells when cultured with 
3 mol% Ga doped BAG at 10 mg/ml and at higher concentrations. Another factor could be the 
faster growth rate and confluence of Saos-2 cells during the culture.  
 
Increasing evidence in the literature indicates that the stimulatory effects of BAGs are 
attributed to their dissolution products. Indirect contact experiments were conducted to 
elucidate whether the dissolution products released from 3 mol% Ga doped BAG and 45S5 
Bioglass® exerted a cytotoxic effect on Saos-2 cells and MSCs. The results demonstrated that 
the cytotoxicity of dissolution products was concentration dependent. This effect was also 
observed for conditioned DMEM-Hams/F12 media generated under static and shaker 
incubation conditions, the degree of cytotoxicity varied. Viability was only observed for non-
treated Saos-2 cells, whereas Saos-2 cells cultured with dissolution products of 45S5 Bioglass® 
and 3 mol% Ga doped BAG showed reduced viability. The magnitude of cytotoxicity varied 
between the two glasses, with 45S5 Bioglass® presenting a slightly greater cytotoxic effect. 
This outcome was noted for conditioned DMEM-Hams/F12 media generated under static and 
shaker incubation conditions. Saos-2 cell viability was significantly reduced when treated with 
conditioned media generated under shaker incubating conditions. Similar results were also 
observed for MSCs when treated with conditioned DMEM-Hams/F12 media with 45S5 
Bioglass® and 3 mol% Ga doped BAG dissolution products generated under static and shaker 
incubating conditions. In addition, phase bright images of Saos-2 cells and MSCs treated with 
variable concentrations of 3 mol% Ga doped BAG and 45S5 Bioglass® dissolution products at 
variable concentrations, support the MTT assay results. The cells appeared to reduce in size 
and number as the concentration increased. 
 
The cytotoxic effect of 45S5 Bioglass® could be attributed to the slow degradation rate of 3 
mol% Ga doped BAG. Franchini et al., (2012) found that increasing the concentration of Ga3+ 
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ions in the 45S5 Bioglass® glass system reduced the amount of Ca2+ and Na+ ions leached into 
solution. The concentration of Ca2+ and Na+ ions leached from 45S5 Bioglass® was reported to 
be 3600 ppm and 245 ppm, whereas for 3.5% Ga doped BAG 3490 ppm and 101 ppm was 
reported, after 1 day of SBF soaking.  Furthermore, the leaching of Ga3+ was found to be very 
slow due to the participation of gallium as a network former along with silicon and its high 
electric charge. Due to these two factors the release of Ga3+ ions from the glass system into the 
solution becomes a slow process (Franchini et al., 2012). Nevertheless, the concentration of 
Ga3+ ions following a 30 day soaking period in solution did not exceed its toxicity level of 14 
ppm (Franchini et al., 2012; Bernstein, 1998).  
 
It is important to know the extracellular concentration of dissolution products needed to 
mediate controlled cellular responses. Xynos et al. (2000) observed that the dissolution 
products of 45S5 Bioglass® activated several families of genes, including genes known to 
control and facilitate osteoblast proliferation, differentiation and extracellular matrix 
production. Based on Xynos et al. (2000) studies Hench stated that approximately 17 – 20 ppm 
of soluble Si4+ and 88 – 100 ppm of soluble Ca2+ ions are required for the up-regulation of 
several osteogenic genes (Hench et al., 2004). At present it is unknown which dissolution 
product is responsible for cell activation and the exact mechanisms of interaction between the 
ionic products and cells also remains unclear. However, the role of Ca2+ in bone metabolism is 
well established, and the ability of extracellular Ca2+ to regulate cell specific responses has only 
recently been demonstrated. Increased levels of extracellular Ca2+ enhance osteoblast 
proliferation and migration. Although the mechanism by which osteoblasts respond to Ca2+ is 
unclear, one possibility is that Ca2+ acts on the G-protein coupled extracellular calcium sensing 
receptor (CaSR) (Pierre, 2010). The CaSR plays a key role in maintaining extracellular Ca2+ 
ion concentration through its action on PTH secretion (Brown et al., 1998). Yamaguchi et al. 
(1998) identified that the osteoblast-like MC3T3 cells possess both CaSR protein and mRNA 
following exposure to Ca2+. Additionally, Chattopadhyay et al. (2004) found that treatment of 
rat calvarial osteoblasts with Ca2+ enhanced CaSR mRNA expression, as well as up regulating 
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cyclin D genes, which are involved in cell proliferation. Previous work has demonstrated that 
Si4+ is associated with the formation and calcification of bone tissue (Carlisle et al., 1981; Hott 
et al., 1993). Keeting et al. (1992) found that Si4+ induced proliferation and differentiation of 
cells of the osteoblast lineage. They reported that Si4+ ions increased DNA synthesis and also 
ALP activity and OCN release. Similarly, Tousi et al. (2013) found enhanced OCN gene 
expression and biomineralisation in osteoblasts treated with Si4. Although, Si4+ is known to be 
associated with the formation and calcification of bone tissue, a cellular receptor has not been 
identified (Xynos et al., 2000).  
 
Valerio et al. (2004) found that viability of osteoblasts decreased as the concentration of Ca2+ 
ions in the media increased (> 300 mg/ml). Maeno et al., (2005) also demonstrated that 
extracellular Ca2+ concentrations greater than 10 mmol are cytotoxic. Moreover, high Ca2+ 
concentrations of 80 – 109 ppm have been shown to reduce Saos-2 cells proliferation when 
exposed to mesoporous BAG 85 (85 mol%  SiO2, 10 mol%  CaO, 5 mol% P2O5) (Alcaide et 
al., 2010). Although these authors worked with different glass compositions, the size of the 
BAG particles were smaller to those of the 45S5 Bioglass® used in the studies of Xynos et al.  
(2000). Valerio et al. (2004) worked with 35µm and Alcaide et al., (2005) with 300-355µm, 
whereas the particle size of 45S5 Bioglass® in the Xynos et al. (2000) studies ranged between 
300-710µm. Finer powders exhibit larger surface areas, and therefore they provide more 
exposed surface for dissolution (Sepulveda et al., 2001). This could explain as to why 45S5 
Bioglass® and 3 mol% Ga doped BAG exhibited cytotoxicity against Saos-2 cells and MSCs, 
as the size of the particles was < 63µm. Furthermore, the highest concentration of 10 mg/ml 
reduced Sasos-2 and MSC cell viability, particularly for shaker conditioned media. Jones et al. 
(2001) found that the dissolution of the active products into solution increased as glass particle 
concentration in solution increased.   
 
In this study the alkalinisation of conditioned DMEM-Hams/F12 media was neutralised to 
investigate whether cell viability was influenced by the dissolution products or pH. Saos-2 cell 
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viability following pH neutralisation of 3 mol% Ga doped BAG conditioned DMEM-
Hams/F12 media generated under static and shaker incubating conditions was similar to Saos-
2 cells cultured with alkaline conditioned DMEM-Hams/F12 media. However,  dissolution 
products of 45S5 Bioglass® increased the metabolic activity of Saso-2 cells following pH 
neutralisation, particularly at 2.5 mg/ml. Viability of Saos-2 cells cultured with neutralised 
conditioned DMEM-Hams/F12 media generated under shaker incubation conditions decreased 
at 10 mg/ml, whereas when cultured with alkaline media a decrease was seen for 5 mg/ml too. 
Similar results were observed for MSCs however dissolution products of 45S5 Bioglass® 
present in static conditioned media significantly increased MSC viability compared to control 
group (0 mg/ml) and Saos-2 cells. These findings indicate that cytotoxicity of 45S5 Bioglass® 
and 3 mol% Ga doped BAG is dependent on both the pH and the presence of high levels of 
dissolution products. These results contradict the findings of Silver et al. (2001) who 
demonstrated that 45S5 Bioglass® enhanced osteoblast proliferation, due to the external 
alkalisation. In their study 45S5 Bioglass® did cause alkalisation as a pH reading of 7.71 was 
reported, however in the current study the pH values were greater than 7.71 for all 
concentrations tested. This difference could be attributed to the particle size, as Silver et al. 
(2001) used particles ranging from 90-150µm, whilst < 63µm were used in the current study.  
 
BAGs increase pH when immersed into physiological solutions due to the reactions that take 
place at the surface. The release of Ca2+ and Na+ ions are responsible for the alkalinisation of 
the surrounding solution. The disappearance of protons (H+) becomes inevitable following the 
release of Na+ and Ca2+ ions, as they are required for the formation of silanol bonds (Si – OH) 
on the glass surface. Formation of the silanol bonds is the first reaction step in the establishment 
of the HCA layer:  
 
Si – O- Na+ + H+ + OH-                Si – OH+ + Na+ (aq) + OH-  
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The leaching of the dissolution products into the surrounding solution would also mean 
increased soluble ion content within the cell. Changes in intracellular Ca2+ are essential 
regulators of many physiological processes including proliferation, gene expression, oxidative 
stress and apoptosis (Bernardi and Rasola. 2007; Labbaf et al., 2011). Overload of the 
intracellular Ca2+ levels affects mitochondrial function, ultimately leading to cell death (Giorgi 
et al., 2008). Adams et al. (2000) demonstrated that in the presence of Ca2+ ions, primary human 
osteoblasts exhibited characteristics of apoptosis, including contraction of the cells, release of 
osteoblasts from the surface and loss of contact with neighbouring cells and a marked change 
in the mitochondrial membrane potential. Therefore, the decrease in cell viability observed for 
Saos-2 cells and MSCs cultured in shaker conditioned DMEM-Hams/F12 media for the higher 
concentrations could be attributed to the apoptotic inducing mechanisms of Ca2+ ions. Under 
shaker incubation conditions high levels of Ca2+ ions are expected because the particles are 
suspended in solution and therefore, are far more likely to come into contact with the solution 
resulting in increased dissolution. 
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3.6 CONCLUSION  
The particles and dissolution products of 3 mol% Ga doped BAG did not promote proliferation 
when tested against MSCs and osteoblast-like Saos-2 cells. 45S5 Bioglass® dissolution 
products exerted greater cytotoxicity, however following pH neutralisation increased viability 
of both cell types was seen. It is possible that particle size as well as glass composition are 
important factors to consider when fabricating BAGs.  
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CHAPTER FOUR 
 
FINAL DISCUSSION and FUTURE WORK 
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4.1 DISCUSSION AND FUTURE WORK 
Implant failure due to interfacial instability and infection leads to reduced implant survivability 
and as a result revision surgery. It has been estimated that annually 1 million hip replacement 
surgeries are performed and more than 250,000 knee replacements, worldwide (Schierholz and 
Beuth, 2001). The implications associated with revision surgery include patient trauma, 
prolonged hospitalisation, as well as health and social costs. It has been reported that it costs 
the NHS £9,655 to replace a single knee arthroplasty and revision surgery due to infection costs 
£30,011 (Kallala et al., 2015). The number of replacements and costs are expected to increase 
in the future, in light of the ageing population as it has been forecasted  that by 2050 nearly one 
in five people will be over the age of 60 (Hench et al., 2010). The limitations of current 
orthopaedic implants has pushed research to explore alternative avenues and one such potential 
avenue is the use of BAGs. Bioactive glasses such as the 45S5 Bioglass® have shown great 
clinical success, due to their ability to regenerate living tissue. Furthermore they have also been 
shown to exhibit antibacterial activity when used as therapeutic materials and therefore would 
be ideal implants (Munukka et al., 2007; Mortazavi et al., 2009). 
 
The objectives of chapter 2 were to evaluate the antibacterial efficacy of 3% Ga doped BAG, 
as well as investigating and comparing the antibacterial activity of 45S5 Bioglass®. The results 
of the work can be summarised briefly as follows:  
(1) Doping the silicate glass system with 3 mol% Ga3+ did not enhance antibacterial activity, 
as similar results were observed for both BAGs. This suggests that Ga3+ ions do not possess 
greater antibacterial efficacy as the other components found within the 45S5 Bioglass® system. 
However, Ga3+ may not have been released from the glass system, as it has been reported that 
Ga3+ ions increase connectivity of BAGs and thus act as a network former (Valappil et al., 
2008; Franchini et al., 2012). Further studies could utilise inductively coupled plasma-mass 
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spectrometry (ICP-MS) to investigate the dissolution rate of Ga3+ions in the silicate glass 
system. 
 (2) The antibacterial activity of both BAGs was concentration dependent. This was observed 
for the lower (2.5 mg/ml, 5 mg/ml and 10 mg/ml) and higher (25 mg/ml, 50 mg/ml and 100 
mg/ml) concentrations tested. The antibacterial effect increased as glass concentration 
increased because of the greater quantities of cations released from the BAGs. The 
inconsistency in the literature regarding whether BAGs possess antibacterial activity could be 
attributed to the concentration levels used. Several authors have reported antibacterial efficacy 
as the concentrations they used ranged from 10 mg/ml – 100 mg/ml (Munukka et al., 2008; Hu 
et al., 2008; Allan et al., 2001; Mortzavi et al., 2009). However, Bellantone et al. (2002) 
demonstrated that BAGs are not antibacterial, which could be due to the low levels of 
concentrations tested (0.05 – 1 mg/ml).  
(3) 3 mol% Ga doped BAG and 45S5 Bioglass® particles did not exhibit a broad-spectrum 
antibacterial effect, as growth reduction was only observed for E.coli and not S. aureus. The 
difference between E. coli and S. aureus could be due to their cell structures. As mentioned 
previously S. aureus lacks an outer membrane but its cell wall is mainly composed of a thick 
peptidoglycan layer. It can be assumed that the dissolution products, chiefly Ca2+ and Na+ ions 
released from the BAG particles bonded to the peptidoglycan layer which provides highly 
charged anionic clusters (Doyle et al., 1980; Hughes et al., 1973). As shown in the SEM 
images, this could be the reason as to why a higher number of S. aureus were attached onto the 
particles. Because SEM analysis does not indicate whether the attached S. aureus are viable or 
non-viable, this warrants further investigation.  
However, the peptidoglycan layer of E. coli is encased within an outer membrane which 
consists of pore proteins through which the dissolution products can enter the cell, resulting in 
cell death.  
(4) The antibacterial mechanism of both BAGs is dependent on pH and particle presence as the 
dissolution products in the absence of the particles were unable to reduce bacterial growth. Hu 
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et al. (2009) and Zhang et al. (2008) found that the local pH value on the surface of 45S5 
Bioglass® particles was higher than that of the area far from the particles. An elevated pH 
disturbs the pH gradient and structure of the bacterial membrane, leading to increased toxicity 
and structural collapse.  
(5) The incubation conditions influenced the results, as particles under shaker incubation 
conditions caused a significant antibacterial effect. The agitation rate influences the rate of 
glass powder dissolution as it exposes more surfaces, whereas under static conditions the 
saturated area at the particle surface is not carried away and thus reducing the rate of dissolution 
(Jones et al., 2001).  
 
The objectives of chapter 3 were to evaluate the cytotoxic effect of 3 mol% Ga doped BAG on 
growth and viability of osteoblast-like cells (Saos-2) and bone marrow derived MSCs. 
Cytotoxic effect of 45S5 Bioglass® was also investigated for comparison purposes. The results 
of the current study can be summarised briefly as follows: 
(1) The particles of 3 mol% Ga doped BAG failed to affect the viability of MSCs and Saos-2 
cells. However, 3 mol% Ga doped BAG exhibited a similar concentration-dependent cytotoxic 
effect as 45S5 Bioglass®. This could be attributed to the surface characteristics of both BAGs, 
which were not conducive for cell attachment and thus preventing cell growth. Gough et al. 
(2003) have reported that a rough surface with a HCA layer is required for osteoblast 
attachment. In this study the surfaces of 45S5 Bioglass® and 3 mol% Ga doped BAG were 
smooth as shown in the SEM images.  
Furthermore, it was found that 3 mol% Ga doped BAG exerted a greater cytotoxic effect at 10 
mg/ml, particularly against Saos-2 cells. Since, Saos-2 cells are a tumour cell line they probably 
were susceptible to the antineoplastic action of Ga3+ ions, which interfere with cellular 
metabolism due to the chemical similarity shared with Fe3+ ions.  
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(2) Like the particles the dissolution products also exhibited a concentration-dependent 
cytotoxic effect. It has been established that when BAGs are immersed into solution they 
release Ca2+ and Na+ ions which increase the aqueous pH. High concentrations of Ca2+ ions (80 
– 109 ppm) have been shown to reduce osteoblast cell proliferation (Valerio et al., 2004; Maeno 
et al., 2005; Alcaide et al., 2010). However, dissolution studies were not conducted to 
determine the rate at which the inorganic ions were released when immersed into an aqueous 
environment. Future experiments could therefore incorporate ICP-MS to quantify then 
dissolution ions present in DMEM/Ham’s-f12 culture media.  
(3) Following pH neutralisation an increase in viability was observed for both cell types at the 
lower concentrations (2.5 mg/ml and 5 mg/ml) of 45S5 Bioglass. According to the in vitro 
studies of Xynos et al. (2001 and 2000) dissolution products activate several families of genes, 
including genes known to control and mediate osteoblast proliferation, differentiation and 
extracellular matrix production. Therefore it is important to assess whether the lower 
concentrations of Ga3+ doped BAG dissolution products induce MSC differentiation towards 
osteogenesis, by measuring the expression of early and late osteogenic genes. Furthermore, the 
ability of Ga3+ doped BAG to stimulate pre-osteoblast maturation should also be determined. 
(4) The incubation methods employed influenced the outcome, as conditioned media generated 
under shaker incubation conditions displayed a greater cytotoxic effect against both cell types. 
As mentioned earlier the agitation rate influences glass dissolution, therefore it can be assumed 
that a greater quantity of dissolution products were released under shaker incubation conditions 
from both glass systems. 
 
The current work illustrates that incorporating 3 mol% Ga within the silicate glass system does 
not enhance the biological properties, possibly due to the network forming properties of Ga3+ 
ions. However, previous studies have reported that glass systems with lower concentrations of 
Ga3+ ions have improved rates of glass solubility, and as a result biological properties. 
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Therefore, it is important to improve and develop novel glass compositions for clinical 
applications.  
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Figure A.1. Mean (n=2) colony forming units (CFU) of S. aureus cell suspension correlated 
to turbidity measured at an absorbance of 600 nm. 
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Figure A.2 Mean (n=2) colony forming units (CFU) of E. coli cell suspension correlated to 
turbidity measured at an absorbance of 600 nm. 
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Figure A.3 Fluorescent microscopy images at x10 objective are shown for LIVE/DEAD 
staining of Saos-2 cells cultured with and without 3 mol% Ga doped BAG and 45S5 Bioglass® 
particles at 100 mg/ml for 96 hours. (A) Live (green) Saos-2 cells cultured without 3 mol% Ga 
doped BAG and 45S5 Bioglass® particles, (B) dead (red) Saos-2 cells cultured without 3 mol% 
Ga doped BAG and 45S5 Bioglass®, (C) 45S5 Bioglass® particles stained with Calcein-AM 
without the presence of live Saos-2 cells, (D) 45S5 Bioglass®  particles stained with Propodium 
iodide without the presence of dead Saos-2 cells, (E) 3 mol% Ga doped BAG stained with 
Calcein-AM without the presence of live Saos-2 cells, and (F) 3 mol% Ga doped BAG  stained 
with Propodium iodide without the presence of dead Saos-2 cells. Bar indicates 100 µm. 
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